Data / Research funding / Tobacco
Tobacco: 1,161 NIH awards ($1.5B) to 260 organizations
1,161 NIH awards ($1.5B) in the NIH spending category Tobacco, to 260 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 1,161 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Abramson Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $48,027,008 | January 15, 1997 | May 31, 2026 | VONDERHEIDE, ROBERT H. | reporter.nih.gov |
| Monitoring the Future: Drug Use & Lifestyles of American Youth (Supp1: Nicotine Pouch and E-cigarette Use Among US Adolescents: National Estimates of Brand Use and Flavor Preferences) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $29,078,476 | June 28, 1975 | March 31, 2027 | MIECH, RICHARD A | reporter.nih.gov |
| Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,809,662 | September 24, 2021 | December 31, 2026 | ALLEN, MICHELE L | reporter.nih.gov |
| Center for Research, Health and Society | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $21,943,481 | September 24, 2021 | June 30, 2027 | CORNELL, CAROL ELLEN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $20,980,807 | December 1, 1996 | February 28, 2029 | MAITRA, ANIRBAN | reporter.nih.gov |
| Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $20,420,182 | September 30, 2013 | August 31, 2028 | KRISHNAN-SARIN, SUCHITRA | reporter.nih.gov |
| IND-enabling Studies in Support of First in Human Safety Studies of a Novel Anti-Nicotine Human Monoclonal Antibody | NIH | National Institute on Drug Abuse | 2023 to 2025 | $13,125,765 | May 1, 2023 | April 30, 2027 | KALNIK, MATTHEW W | reporter.nih.gov |
| Center for Addiction and Disease Risk Exacerbation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,487,946 | August 1, 2019 | July 31, 2029 | MONTI, PETER M. | reporter.nih.gov |
| Environmental Exposure and Cardiometabolic Disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $12,324,355 | September 1, 2017 | June 30, 2027 | SRIVASTAVA, SANJAY | reporter.nih.gov |
| POPULATION ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY PERIOD OF PERFORMANCE: 02/01/2024 - 11/30/2030. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,560,337 | February 1, 2024 | November 30, 2029 | CARUSI, CHARLES | reporter.nih.gov |
| Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study | NIH | National Cancer Institute | 2021 to 2025 | $9,428,812 | April 19, 2016 | August 31, 2026 | CUMMINGS, KENNETH MICHAEL | reporter.nih.gov |
| Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers | NIH | National Institute on Drug Abuse | 2023 to 2025 | $9,048,057 | September 30, 2023 | August 31, 2026 | COSFORD, NICHOLAS DAVID | reporter.nih.gov |
| INTERNAL AND EXTERNAL COMMUNICATIONS AND DISSEMINATION SUPPORT FOR DCCPS | NIH | National Cancer Institute | 2022 to 2024 | $8,942,190 | September 15, 2022 | September 14, 2025 | KILGORE, ELIZABETH | reporter.nih.gov |
| Clinical development of an mGlu2 positive allosteric modulator to treat nicotine addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $7,715,052 | August 15, 2020 | July 31, 2025 | COSFORD, NICHOLAS DAVID | reporter.nih.gov |
| PROMINENT - UCSF | NIH | National Cancer Institute | 2022 to 2025 | $6,721,823 | June 22, 2022 | May 31, 2026 | BALMAIN, ALLAN | reporter.nih.gov |
| Understanding the Origins of Early COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,605,820 | May 1, 2020 | April 30, 2025 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations | NIH | National Cancer Institute | 2021 to 2023 | $6,033,066 | April 15, 2018 | July 31, 2025 | RITZWOLLER, DEBRA P | reporter.nih.gov |
| First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,613,363 | August 1, 2021 | April 30, 2024 | ZAVERI, NURULAIN T | reporter.nih.gov |
| ASPiRE: Advancing Science & Practice in the Retail Environment | NIH | National Cancer Institute | 2021 to 2023 | $5,479,825 | September 1, 2018 | August 31, 2025 | RIBISL, KURT M. | reporter.nih.gov |
| STAKEHOLDER ENGAGEMENT AND OUTREACH SUPPORT FOR HEALTH BEHAVIOR CHANGE AND CANCER CONTROL RESOURCES | NIH | National Cancer Institute | 2023 to 2025 | $5,325,929 | September 1, 2023 | August 31, 2026 | KENDRICK, BRANDON | reporter.nih.gov |
| Vitamin C to Decrease Effects of Smoking during Pregnancy on Offspring Airway Function, Airway Size, and Epigenetic Correlates: VCSIP cohort follow-up through 10 Years of Age | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,223,986 | August 15, 2023 | May 31, 2028 | MCEVOY, CYNTHIA T | reporter.nih.gov |
| Chromosome Instability Drives Metal-Induced Lung Cancer | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $5,203,730 | August 1, 2021 | June 30, 2029 | WISE, JOHN PIERCE | reporter.nih.gov |
| Continued follow-up of the Vitamin C and Smoking in Pregnancy (VCSIP) cohorts through the ECHO consortium, focus on Echo-wide protocols, respiratory outcomes, airway function, and epigenetic changes | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $5,158,536 | September 21, 2016 | May 31, 2030 | MCEVOY, CYNTHIA T | reporter.nih.gov |
| Evaluation of Smoke-Free Housing Policy Impacts on Tobacco Smoke Exposure and Health Outcomes | NIH | National Cancer Institute | 2021 to 2023 | $4,874,420 | December 15, 2017 | November 30, 2023 | THORPE, LORNA | reporter.nih.gov |
| Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions | NIH | National Cancer Institute | 2022 to 2025 | $4,678,848 | December 3, 2022 | August 31, 2026 | MEZA, RAFAEL | reporter.nih.gov |
| DEVELOPMENT, MAINTENANCE, AND PROMOTION OF NCI SPONSORED BEHAVIORAL AND MOBILE HEALTH INITIATIVES. | NIH | National Cancer Institute | 2021 to 2024 | $4,522,410 | September 15, 2021 | September 14, 2025 | SCHWARZ, MARY | reporter.nih.gov |
| Leveraging the National Cancer Institute’s Cancer Center Cessation Initiative (C3I) Program to Evaluate and Transform Smoking Cessation Treatment in Cancer Care | NIH | National Cancer Institute | 2021 to 2025 | $4,423,867 | August 1, 2015 | August 31, 2029 | FIORE, MICHAEL C | reporter.nih.gov |
| Investigating the Roles of Patient Beliefs, and Physician Communication on Disparities in Lung Cancer Screening | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $4,149,463 | September 20, 2021 | May 31, 2027 | KALE, MINAL S | reporter.nih.gov |
| Integrating tobacco use cessation into HIV Care and Treatment in Ministry of Health Facilities in Kisumu County, Kenya | NIH | National Cancer Institute | 2021 to 2025 | $4,048,603 | September 16, 2021 | August 31, 2026 | BIALOUS, STELLA AGUINAGA | reporter.nih.gov |
| 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,972,165 | September 30, 2021 | June 30, 2026 | JOHNSON, MATTHEW WAYNE | reporter.nih.gov |
| Consortium on Methods Evaluating Tobacco (COMET): FilterVentilation and Product Standards | NIH | National Cancer Institute | 2021 to 2022 | $3,820,230 | September 20, 2017 | August 31, 2024 | HATSUKAMI, DOROTHY K | reporter.nih.gov |
| Electronic Pediatric Office Systems to Support Treatment for Parental Tobacco Use | NIH | National Cancer Institute | 2021 to 2024 | $3,780,101 | January 1, 2020 | December 31, 2025 | WINICKOFF, JONATHAN P | reporter.nih.gov |
| Project SMART: Social Media Anti-vaping Messages to Reduce ENDS Use Among Sexual and Gender Minority Teens | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,741,884 | July 1, 2021 | April 30, 2027 | TAN, ANDY SL | reporter.nih.gov |
| Neurotoxic and neurodegenerative risks from chronic exposure to metal mixtures in e-cigarette aerosol | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,656,277 | September 8, 2021 | June 30, 2027 | RE, DIANE BERENGERE | reporter.nih.gov |
| Assessment of Biomarkers in Children to Help Parents Quit Tobacco | NIH | National Cancer Institute | 2021 to 2025 | $3,629,865 | September 1, 2020 | June 30, 2026 | WINICKOFF, JONATHAN P | reporter.nih.gov |
| A prospective study of male factors, fertility, and pregnancy outcomes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,601,732 | August 5, 2021 | April 30, 2027 | WISE, LAUREN A | reporter.nih.gov |
| Empathic Communication Skills Training to Reduce Lung Cancer Stigma | NIH | National Cancer Institute | 2021 to 2025 | $3,592,601 | September 9, 2021 | August 31, 2027 | BANERJEE, SMITA | reporter.nih.gov |
| Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,545,738 | September 27, 2021 | August 31, 2027 | GORDON, JUDITH SARAH | reporter.nih.gov |
| Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trial | NIH | National Cancer Institute | 2023 to 2025 | $3,532,837 | September 20, 2023 | August 31, 2028 | BRICKER, JONATHAN B | reporter.nih.gov |
| Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,483,414 | September 10, 2020 | August 31, 2027 | CASKEY, RACHEL | reporter.nih.gov |
| mHealth Messaging to Motivate Quitline use and Quitting among Persons Living With HIV in Vietnam (M2Q2-HIV) | NIH | National Cancer Institute | 2021 to 2025 | $3,472,107 | September 17, 2021 | August 31, 2027 | SADASIVAM, RAJANI | reporter.nih.gov |
| 1/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,465,062 | September 10, 2023 | August 31, 2029 | HANSEL, NADIA N | reporter.nih.gov |
| Patterns of Cardiopulmonary health across the life course | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,464,936 | September 1, 2021 | May 31, 2027 | KHAN, SADIYA SANA | reporter.nih.gov |
| Metformin for chemoprevention of lung cancer in obese subjects at high risk | NIH | National Cancer Institute | 2021 to 2025 | $3,423,650 | August 1, 2021 | July 31, 2027 | YENDAMURI, SAIKRISHNA | reporter.nih.gov |
| Optimizing Lung Cancer Screening in Cancer Survivors | NIH | National Cancer Institute | 2021 to 2025 | $3,415,788 | July 15, 2021 | June 30, 2027 | WISNIVESKY, JUAN P | reporter.nih.gov |
| Population Modeling of Bladder Cancer Detection and Control | NIH | National Cancer Institute | 2021 to 2025 | $3,415,778 | September 13, 2021 | August 31, 2026 | TRIKALINOS, THOMAS | reporter.nih.gov |
| Role of MIF and CD74 in the pathogenesis of emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,410,379 | January 1, 2021 | December 31, 2026 | BUCALA, RICHARD J | reporter.nih.gov |
| Metal Exposure and Subclinical Lung Disease in Adult E-cigarette Users | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,409,256 | February 15, 2021 | January 31, 2027 | OELSNER, ELIZABETH | reporter.nih.gov |
| Evaluation of the Be Vape Free Curriculum of the Tobacco Prevention Toolkit | NIH | National Cancer Institute | 2021 to 2025 | $3,364,734 | September 2, 2021 | August 31, 2026 | HALPERN-FELSHER, BONNIE L | reporter.nih.gov |
| Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,331,422 | August 24, 2021 | April 30, 2027 | CAI, QIUYIN | reporter.nih.gov |
| A community-based trial of a voluntary smoke-free home intervention in permanent supportive housing for formerly homeless adults | NIH | National Cancer Institute | 2021 to 2025 | $3,303,677 | March 3, 2021 | February 28, 2026 | VIJAYARAGHAVAN, MAYA | reporter.nih.gov |
| Assessing the Effects of Cigar and Cigarillo Social Media Promotion on Tobacco and Marijuana Use | NIH | National Cancer Institute | 2021 to 2025 | $3,291,137 | December 2, 2020 | November 30, 2026 | KOSTYGINA, GANNA | reporter.nih.gov |
| Genomic and Epigenomic Mechanisms of Maternal E-Cigarette induced Abnormal Brain Development | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,290,961 | April 15, 2023 | January 31, 2028 | WANG, CHARLES | reporter.nih.gov |
| Impact of HIV, oral microbiome and mycobiome on oral HPV persistence | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $3,289,768 | September 1, 2022 | August 31, 2027 | BURK, ROBERT D | reporter.nih.gov |
| Expanding population-level interventions to help more low-income smokers quit | NIH | National Cancer Institute | 2021 to 2023 | $3,284,616 | July 23, 2019 | June 30, 2024 | KREUTER, MATTHEW W. | reporter.nih.gov |
| Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,280,008 | July 1, 2020 | May 31, 2025 | FANTRY, LORI E | reporter.nih.gov |
| Vaping Nicotine and Cannabis Across Adolescence and Young Adulthood | NIH | National Cancer Institute | 2021 to 2024 | $3,258,517 | September 20, 2019 | August 31, 2025 | LEVENTHAL, ADAM MATTHEW | reporter.nih.gov |
| Delivery of a Smoking Cessation Induction Intervention Via Virtual Reality Headset During a Dental Cleaning | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $3,211,741 | August 1, 2019 | July 31, 2026 | BORRELLI, BELINDA | reporter.nih.gov |
| Discovering Our Story, to develop the Chemawa Journey of Transformation | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,201,461 | April 1, 2021 | February 28, 2027 | EVANS-CAMPBELL, TERESA A | reporter.nih.gov |
| Reducing lung cancer by decoding the link between neighborhood exposure and biological responses (RECODE) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,171,260 | May 6, 2021 | January 31, 2027 | KIM, SAGE J. | reporter.nih.gov |
| A controlled evaluation of abstinence-induced withdrawal and motivation to vape/smoke among daily ENDS users vs. cigarette smokers | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,167,936 | June 15, 2022 | April 30, 2027 | HAWK, LARRY W | reporter.nih.gov |
| Longitudinal mixed method investigation of social networks and affective states as determinants of smoking behavior among cancer patient | NIH | National Cancer Institute | 2021 to 2025 | $3,134,857 | July 13, 2021 | June 30, 2027 | POGHOSYAN, HERMINE | reporter.nih.gov |
| Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults | NIH | National Cancer Institute | 2021 to 2025 | $3,067,733 | April 1, 2021 | March 31, 2026 | KENDZOR, DARLA ELIZABETH | reporter.nih.gov |
| High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck | NIH | National Cancer Institute | 2021 to 2025 | $3,062,587 | September 21, 2021 | August 31, 2027 | HECHT, STEPHEN S | reporter.nih.gov |
| Cannabis and Nicotine Co-Use Influences on Protracted Development of Neural Structure and Function | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,058,239 | August 15, 2021 | May 31, 2027 | JACOBUS, JOANNA | reporter.nih.gov |
| Pathogenic Exosomes in COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,057,675 | April 1, 2023 | March 31, 2030 | BLALOCK, J EDWIN | reporter.nih.gov |
| Augmented Reality as an Adjunct to Quitline Counseling for Smoking Cessation | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,040,122 | July 1, 2022 | May 31, 2027 | VINCI, CHRISTINE | reporter.nih.gov |
| Assessing the impact of vaping control policies at the school, local and state levels | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,034,662 | September 1, 2022 | July 31, 2027 | LEVY, DOUGLAS | reporter.nih.gov |
| Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement for Tobacco Dependence and Other Drug use in Methadone Treatment | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,032,237 | September 30, 2022 | August 31, 2027 | COOPERMAN, NINA | reporter.nih.gov |
| Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia | NIH | National Cancer Institute | 2022 to 2025 | $3,031,959 | September 8, 2022 | August 31, 2027 | LITTLE, MELISSA ASHLEY | reporter.nih.gov |
| Determining the impact of cannabis use and severity on tobacco cessation outcomes: A prospective tobacco treatment trial | NIH | National Cancer Institute | 2021 to 2025 | $3,018,031 | July 1, 2019 | August 31, 2027 | MCCLURE, ERIN A | reporter.nih.gov |
| Atherosclerosis in cocaine addiction: imaging risk with PET/MR | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,015,410 | June 1, 2022 | March 31, 2027 | ALIA-KLEIN, NELLY | reporter.nih.gov |
| Translating buccal nanocytology for lung cancer screening into clinical practice | NIH | National Cancer Institute | 2021 to 2025 | $3,005,920 | April 15, 2018 | July 31, 2029 | BACKMAN, VADIM | reporter.nih.gov |
| Building Implementation Science Research Capacity to advance cancer prevention and care in Uganda and Zambia | NIH | National Cancer Institute | 2021 to 2024 | $3,003,899 | September 15, 2021 | August 31, 2026 | WIPFLI, HEATHER L | reporter.nih.gov |
| Local Flavor Policies to Enhance Equity in Tobacco | NIH | National Cancer Institute | 2021 to 2025 | $2,999,270 | April 8, 2021 | March 31, 2027 | ROSE, SHYANIKA W | reporter.nih.gov |
| Hepatocyte Growth Factor Signaling and Airspace Maintenance | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,997,638 | September 1, 2021 | May 31, 2026 | NEPTUNE, ENID R | reporter.nih.gov |
| Botswana Smoking Abstinence Reinforcement Trial (BSMART) | NIH | National Cancer Institute | 2022 to 2025 | $2,990,959 | September 15, 2022 | August 31, 2027 | CHARURAT, MANHATTAN E | reporter.nih.gov |
| Ending Tobacco Use through Interactive Tailored Messaging for Cambodian People Living with HIV/AIDS (EndIT) | NIH | National Cancer Institute | 2021 to 2025 | $2,979,791 | September 17, 2021 | August 31, 2027 | VIDRINE, DAMON J. | reporter.nih.gov |
| A behavioral economic intervention for low-income smokers | NIH | National Cancer Institute | 2022 to 2025 | $2,975,367 | December 14, 2021 | November 30, 2026 | ROGERS, ERIN | reporter.nih.gov |
| Using nicotine to reverse age-related auditory processing deficits | NIH | National Institute on Aging | 2021 to 2025 | $2,935,681 | January 1, 2021 | December 31, 2026 | METHERATE, RAJU | reporter.nih.gov |
| Testing a Clinician and Patient Intervention to Promote smoking Cessation Among Pregnant Women | NIH | National Cancer Institute | 2021 to 2025 | $2,934,495 | June 1, 2021 | May 31, 2027 | POLLAK, KATHRYN I | reporter.nih.gov |
| The Role of HuR in HIV related COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,901,310 | September 1, 2022 | June 30, 2027 | FORONJY, ROBERT F | reporter.nih.gov |
| A multilevel intervention to personalize and improve tobacco treatment in primary care | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,857,195 | August 1, 2022 | June 30, 2027 | CHEN, LI-SHIUN | reporter.nih.gov |
| Construal level as a novel pathway for affect regulation and cancer control | NIH | National Cancer Institute | 2021 to 2024 | $2,836,437 | April 1, 2020 | March 31, 2026 | BERKMAN, ELLIOT TODD | reporter.nih.gov |
| Determinants and Outcomes of Nicotine Metabolite Ratio in HIV + Smokers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,835,005 | February 10, 2020 | January 31, 2024 | GROSS, ROBERT | reporter.nih.gov |
| Multi Site Randomized Trial of a GLP-1/GIP Receptor Agonist for Smoking Cessation | NIH | National Institute on Drug Abuse | 2025 | $2,828,440 | July 15, 2025 | March 31, 2028 | HENDERSHOT, CHRISTIAN S | reporter.nih.gov |
| An Addictions Neuroclinical Assessment Based Treatment for Smokers with an Alcohol Use Disorder | NIH | National Cancer Institute | 2021 to 2025 | $2,810,761 | May 1, 2021 | April 30, 2027 | MCPHERSON, STERLING M | reporter.nih.gov |
| Improving smoking abstinence outcomes in the African American community through extended treatment | NIH | National Cancer Institute | 2022 to 2025 | $2,801,719 | May 1, 2022 | April 30, 2027 | COX, LISA SANDERSON | reporter.nih.gov |
| Adapting and evaluating a brief advice tobacco intervention in high-reach, low-resource settings in India | NIH | National Cancer Institute | 2021 to 2024 | $2,800,655 | June 1, 2020 | May 31, 2026 | VISWANATH, KASISOMAYAJULA | reporter.nih.gov |
| Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,799,371 | June 1, 2022 | May 31, 2027 | MUKHERJEE, SEMANTI | reporter.nih.gov |
| Addressing Rural Cancer Disparities via Proactive Smoking Cessation Treatment within Primary Care: A Hybrid Type 1 Effectiveness-Implementation Trial of a Scalable Smoking Cessation Electronic Visit | NIH | National Cancer Institute | 2022 to 2025 | $2,798,003 | September 8, 2022 | August 31, 2028 | DAHNE, JENNIFER RENEE | reporter.nih.gov |
| Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,784,669 | August 15, 2021 | July 31, 2025 | MANICHAIKUL, ANI WANG | reporter.nih.gov |
| Nicotinic Modulation of the Cognitive Control System in Late-Life Depression | NIH | National Institute of Mental Health | 2023 to 2025 | $2,784,647 | July 29, 2020 | November 30, 2026 | ANDREWS, PATRICIA SERRANO | reporter.nih.gov |
| Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,769,471 | June 1, 2020 | March 31, 2026 | GROSS, ROBERT | reporter.nih.gov |
| Addressing disparities in tobacco-related diseases by understanding the tobacco industry strategies | NIH | National Cancer Institute | 2022 to 2025 | $2,769,201 | August 1, 2022 | July 31, 2027 | BIALOUS, STELLA AGUINAGA | reporter.nih.gov |
| Context, Subjective and Cognitive Experiences with Patterns of Tobacco and Cannabis Co-Use in Young Adults | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,763,381 | July 1, 2020 | April 30, 2026 | MERMELSTEIN, ROBIN J. | reporter.nih.gov |
| Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | NIH | National Cancer Institute | 2021 to 2023 | $2,755,707 | August 7, 2020 | April 30, 2024 | PLUNK, ANDREW DUANE | reporter.nih.gov |
| Implementing tobacco use treatment in HIV clinics in Viet Nam | NIH | National Cancer Institute | 2021 to 2024 | $2,744,980 | May 1, 2020 | April 30, 2026 | SHELLEY, DONNA R | reporter.nih.gov |
| Development and Application of Computational Methods for Single Cell DNA Sequencing Data | NIH | National Human Genome Research Institute | 2022 to 2025 | $2,737,551 | September 1, 2022 | June 30, 2027 | PARK, PETER J | reporter.nih.gov |
| Metal Exposure and Early Cardiovascular Risk in Adult E-Cigarette Users | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,730,969 | August 1, 2020 | May 31, 2026 | NAVAS-ACIEN, ANA | reporter.nih.gov |
| Assessing pharmacokinetic and pharmacodynamic variability of Δ9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,720,537 | September 30, 2022 | June 30, 2027 | SMITH, DANIELLE | reporter.nih.gov |
| The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,716,071 | September 28, 2015 | June 30, 2030 | VEGE, SANTHI SWAROOP | reporter.nih.gov |
| TASK ORDER 75N95023F00003 (ACQUISITION, ANALYSIS, TESTING, STORAGE, AND SHIPMENT OF NICOTINE RESEARCH CIGARETTES) UNDER IDIQ NO. 75N95019D00042. | NIH | National Institute on Drug Abuse | 2022 to 2023 | $2,706,674 | September 1, 2023 | November 30, 2024 | MANGUM, KATHERINE | reporter.nih.gov |
| Establishing smoke-free homes with families involved in child protective services: An effectiveness-implementation trial of an integrated program | NIH | National Cancer Institute | 2021 to 2025 | $2,704,547 | January 1, 2021 | December 31, 2026 | SELF-BROWN, SHANNON RENEE | reporter.nih.gov |
| Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers with Cardiopulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,702,372 | March 15, 2022 | February 28, 2027 | PACK, QUINN RUSSELL | reporter.nih.gov |
| Precision prevention strategy to increase uptake and engagement in lung cancer screening and smoking cessation treatment | NIH | National Cancer Institute | 2022 to 2025 | $2,692,512 | March 21, 2022 | February 28, 2027 | RAMSEY, ALEX TAYLOR | reporter.nih.gov |
| Metabolic Control of Stemness in lung epithelial progenitors by FAM13A | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,676,003 | April 1, 2015 | November 30, 2025 | ZHOU, ANNY XIAOBO | reporter.nih.gov |
| Ceramide-Induced Destruction in Emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,661,589 | July 1, 2006 | April 30, 2025 | PETRACHE, IRINA | reporter.nih.gov |
| Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,660,685 | July 15, 2020 | May 31, 2026 | LESAGE, MARK G | reporter.nih.gov |
| Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,657,964 | April 1, 2021 | March 31, 2026 | QUERTERMOUS, THOMAS | reporter.nih.gov |
| Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness. | NIH | National Cancer Institute | 2021 to 2025 | $2,653,805 | September 15, 2021 | August 31, 2027 | GOLUB, JONATHAN E. | reporter.nih.gov |
| The Impact of Standardized Tobacco Product Packaging on Young Adults in the Retail Environment | NIH | National Cancer Institute | 2022 to 2025 | $2,644,353 | May 4, 2022 | April 30, 2026 | SHADEL, WILLIAM G | reporter.nih.gov |
| The potential risks and benefits of electronic cigarettes to older smokers at high risk for lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,641,121 | September 1, 2020 | May 31, 2027 | ROBINSON, JASON D | reporter.nih.gov |
| Testing Peer-led Network Intervention to Prevent Adolescent Vaping | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,631,482 | May 1, 2020 | September 30, 2026 | WYMAN, PETER A | reporter.nih.gov |
| Tobacco Use and Cessation, HIV, and TB in South Africa: Clinical and Economic Outcomes (Clinical and public health approaches to tobacco cessation in South Africa supplement) | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,627,377 | September 1, 2020 | July 31, 2025 | REDDY, KRISHNA P | reporter.nih.gov |
| Understanding the role of area-level factors, smoking, and epigenetics in lung cancer risk across populations groups | NIH | National Cancer Institute | 2022 to 2025 | $2,625,326 | July 1, 2022 | June 30, 2027 | CHENG, IONA C | reporter.nih.gov |
| Social Media, Acculturation and E-cigarette Use among Mexican American College Students in South Texas | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,614,721 | July 25, 2022 | March 31, 2027 | WILKINSON, ANNA VICTORIA | reporter.nih.gov |
| Airway trees in the Anthropocene: Defining resilient airway trees and identifying the candidate mechanisms and etiologic factors that increase susceptibility to tobacco smoke and air pollution | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,605,860 | July 1, 2016 | July 31, 2027 | SMITH, BENJAMIN M. | reporter.nih.gov |
| Promoting Smoke-Free Homes in Rural American Indian Households | NIH | National Cancer Institute | 2022 to 2025 | $2,589,363 | February 10, 2022 | January 31, 2028 | KEGLER, MICHELLE C | reporter.nih.gov |
| Comprehensive molecular characterization of lung cancers in five racial/ethnic groups with disparate risk | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,566,329 | February 25, 2020 | December 31, 2025 | PARK, SUNGSHIM LANI | reporter.nih.gov |
| Multimodal Optical Imaging on the Effect of Maternal Polysubstance Exposure on Fetal Brain Microvessel Function | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,556,302 | January 1, 2016 | July 31, 2027 | LARIN, KIRILL V | reporter.nih.gov |
| Discovery and development of GPR3 agonists for nicotine cessation | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,555,113 | September 30, 2023 | July 31, 2028 | GAY, ELAINE ARRINGTON | reporter.nih.gov |
| Experimental Tobacco Marketplace: Forecasting the Impact of Novel Tax Proposals | NIH | National Cancer Institute | 2022 to 2025 | $2,547,621 | July 15, 2022 | June 30, 2027 | STEIN, JEFFREY SCOTT | reporter.nih.gov |
| Longitudinal Effects of E-cigarette Use on Cardiovascular and Pulmonary Health | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,545,216 | September 6, 2024 | June 30, 2029 | BAKER, TIMOTHY B | reporter.nih.gov |
| Combining Policy and Implementation Science to Optimize Clinical Practice | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,544,378 | April 15, 2022 | February 28, 2027 | TELEM, DANA ALEXA | reporter.nih.gov |
| Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,543,302 | February 19, 2021 | January 31, 2027 | KADARA, HUMAM | reporter.nih.gov |
| 4th Generation e-cigarettes in African American Smokers: Reducing Harm and Quitting Combustible Cigarettes in Dual Users | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,524,937 | May 14, 2022 | February 28, 2027 | NOLLEN, NICOLE L | reporter.nih.gov |
| Interoceptive, Affective, and Cognitive Control Networks that Determine Self-Regulation and Reinforcement Learning of Smoking Decisions | NIH | National Cancer Institute | 2025 | $2,524,071 | September 23, 2025 | August 31, 2029 | LIM, SEUNG LARK | reporter.nih.gov |
| Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients | NIH | National Cancer Institute | 2022 to 2025 | $2,501,120 | June 13, 2022 | May 31, 2027 | KAPILA, YVONNE L | reporter.nih.gov |
| Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use | NIH | National Institute on Drug Abuse | 2022 to 2023 | $2,497,896 | August 1, 2021 | February 29, 2024 | JACOBS, CINDY | reporter.nih.gov |
| A Mechanistic Test of Treatment Strategies to Foster Practice Quitting | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,496,504 | September 15, 2022 | July 31, 2027 | MATHEW, AMANDA R | reporter.nih.gov |
| Digital Media for Cancer Control: Randomized Controlled Trial and Dose Response Effects | NIH | National Cancer Institute | 2021 to 2024 | $2,493,249 | September 17, 2020 | May 31, 2026 | EVANS, W. DOUGLAS | reporter.nih.gov |
| Adapt2Quit – A Machine-Learning, Adaptive Motivational System: RCT for Socio-Economically Disadvantaged smokers” | NIH | National Cancer Institute | 2021 to 2024 | $2,485,256 | April 16, 2020 | March 31, 2026 | SADASIVAM, RAJANI | reporter.nih.gov |
| Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,480,652 | September 10, 2020 | August 31, 2023 | DONENBERG, GERI R | reporter.nih.gov |
| Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,475,804 | September 1, 2020 | June 30, 2026 | ALLEN, SHARON S | reporter.nih.gov |
| Nicotine and Tobacco Messaging on Youth-Oriented Social Media Platforms | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,475,173 | September 20, 2022 | May 31, 2027 | SIDANI, JAIME ELIZABETH | reporter.nih.gov |
| Automatic detection of vaping rate and patterning in the lab and the natural environment using Flexible, Robust Instrumentation of Electronic Nicotine Delivery Systems (FRIENDS) | NIH | National Cancer Institute | 2022 to 2025 | $2,463,407 | July 12, 2022 | June 30, 2027 | HAWK, LARRY W | reporter.nih.gov |
| Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches | NIH | National Cancer Institute | 2021 to 2024 | $2,457,120 | January 15, 2020 | March 19, 2025 | TAN, ANDY SL | reporter.nih.gov |
| CONNECT: COmpreheNsive traiNing and Engagement in Cessation Treatment | NIH | National Cancer Institute | 2021 to 2025 | $2,456,709 | July 1, 2021 | February 28, 2027 | BAILEY, STEFFANI R | reporter.nih.gov |
| Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in Smokers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,456,454 | August 9, 2020 | May 31, 2025 | DIAZ, ALEJANDRO | reporter.nih.gov |
| Electronic Cigarette-derived Oxidants and their Impact on Lung Cancer Development | NIH | National Cancer Institute | 2021 to 2025 | $2,445,242 | June 5, 2020 | May 31, 2027 | FOULDS, JONATHAN | reporter.nih.gov |
| Developing and testing health warning labels on the ENDS device | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,436,829 | June 1, 2021 | April 30, 2027 | MAZIAK, WASIM | reporter.nih.gov |
| Evaluation of genetic, clinical and environmental risk factors to establish effective screening strategies for second primary lung cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,434,380 | May 1, 2018 | April 30, 2026 | HAN, SUMMER S | reporter.nih.gov |
| Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery via Primary Care | NIH | National Cancer Institute | 2022 to 2025 | $2,430,388 | January 19, 2022 | August 31, 2027 | DAHNE, JENNIFER RENEE | reporter.nih.gov |
| Exploring Pathways through which Structural Racism Impacts Children's Environmental Health | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $2,429,089 | September 1, 2023 | May 31, 2025 | WHITWORTH, KRISTINA WALKER | reporter.nih.gov |
| Effectiveness and impact of counseling enhanced with electronic cigarettes for harm reduction in smokers with opioid use disorder | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,424,067 | August 15, 2022 | April 30, 2027 | EL-SHAHAWY, OMAR | reporter.nih.gov |
| Airway Tree Subtyping on Large Cohorts of CT Images for COPD Risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,406,566 | July 1, 2021 | June 30, 2026 | LAINE, ANDREW FRANCIS | reporter.nih.gov |
| Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,389,102 | September 1, 2022 | July 31, 2027 | KADARA, HUMAM | reporter.nih.gov |
| Teen Mothers’ Prenatal Cannabis Use and Co-Use with Tobacco | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,383,979 | May 1, 2019 | August 31, 2025 | DE GENNA, NATACHA | reporter.nih.gov |
| Quit2Heal: Rigorous Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking | NIH | National Cancer Institute | 2021 to 2024 | $2,383,412 | June 1, 2020 | May 31, 2026 | BRICKER, JONATHAN B | reporter.nih.gov |
| Macro-vasculature: A Novel Image Biomarker of Lung Cance | NIH | National Cancer Institute | 2021 to 2024 | $2,378,544 | January 13, 2020 | December 31, 2025 | PU, JIANTAO | reporter.nih.gov |
| Addressing racial disparities in lung cancer screening | NIH | National Cancer Institute | 2021 to 2025 | $2,367,378 | April 5, 2021 | March 31, 2027 | ALDRICH, MELINDA | reporter.nih.gov |
| Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV | NIH | National Cancer Institute | 2021 to 2024 | $2,347,827 | September 13, 2019 | August 31, 2025 | SCHNOLL, ROBERT ADAM | reporter.nih.gov |
| The Impact of Tobacco Control Policies on Health Equity in the United States - MERIT Extension | NIH | National Cancer Institute | 2021 to 2024 | $2,345,823 | December 19, 2017 | November 30, 2024 | FLEISCHER, NANCY | reporter.nih.gov |
| The Interplay of ENDS and Tobacco Control Policy: Impact on the Population Harms of Tobacco | NIH | National Cancer Institute | 2022 to 2025 | $2,344,619 | July 1, 2022 | June 30, 2027 | MACIOSEK, MICHAEL V | reporter.nih.gov |
| Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,343,499 | May 15, 2019 | February 28, 2025 | O'CLEIRIGH, CONALL MICHAEL | reporter.nih.gov |
| Using Social Network Analysis to Understand Peer Influences on ENDS Use | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,336,100 | September 1, 2020 | July 31, 2025 | VALENTE, THOMAS W | reporter.nih.gov |
| Fungal Translocation in Chronic Obstructive Pulmonary Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,331,334 | April 15, 2022 | March 31, 2026 | BON, JESSICA | reporter.nih.gov |
| Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,326,551 | July 1, 2020 | May 31, 2026 | ABBRUSCATO, THOMAS J | reporter.nih.gov |
| Neurobehavioral mechanisms linking childhood adversity to increased risk for smoking | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,323,969 | August 1, 2022 | May 31, 2027 | SWEITZER, MAGGIE M | reporter.nih.gov |
| Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers | NIH | National Cancer Institute | 2021 to 2024 | $2,315,994 | September 7, 2019 | November 30, 2025 | VIDRINE, DAMON J. | reporter.nih.gov |
| A randomized controlled trial to support smoke-free policy compliance in public housing | NIH | National Cancer Institute | 2021 to 2025 | $2,315,269 | August 1, 2020 | November 30, 2026 | HERNANDEZ, DIANA | reporter.nih.gov |
| Integrating Multiple Omics to Illuminate Gene Networks Underlying Cigarette Smoking and Opioids. | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,298,081 | September 30, 2020 | June 30, 2026 | HANCOCK, DANA B | reporter.nih.gov |
| Continued follow-up of the Vitamin C and Smoking in Pregnancy (VCSIP) cohorts through the ECHO consortium, focus on Echo-wide protocols, respiratory outcomes, airway function, and epigenetic changes | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $2,293,146 | September 21, 2016 | May 31, 2025 | MCEVOY, CYNTHIA T | reporter.nih.gov |
| The Development and Evaluation of a Culturally Grounded ENDS Intervention for Rural Hawaiian Youth | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,274,356 | July 1, 2022 | June 30, 2027 | OKAMOTO, SCOTT KIYOSHI | reporter.nih.gov |
| Optimizing Personalized Screening and Diagnostic Decisions for Lung Cancer Based on Dynamic Risk Assessment and Life Expectancy | NIH | National Cancer Institute | 2022 to 2025 | $2,272,686 | June 15, 2022 | May 31, 2027 | TOUMAZIS, IAKOVOS | reporter.nih.gov |
| Phone Enabled Implementation of Cessation Support (PHOENICS) | NIH | National Cancer Institute | 2022 to 2025 | $2,264,697 | September 9, 2022 | August 31, 2027 | SALLOUM, RAMZI GEORGE | reporter.nih.gov |
| Multi-omic networks associated with COPD progression in TOPMed Cohorts | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,263,919 | April 5, 2020 | March 31, 2026 | KECHRIS-MAYS, KATHERINA | reporter.nih.gov |
| Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,258,650 | March 15, 2020 | March 31, 2024 | VILARDAGA, ROGER | reporter.nih.gov |
| Evaluating Lung Cancer Screening Patterns and Outcomes in Diverse Populations and Settings | NIH | National Cancer Institute | 2021 to 2025 | $2,257,907 | September 20, 2017 | May 31, 2028 | HENDERSON, LOUISE | reporter.nih.gov |
| Varenicline and mobile behavioral assistance for tobacco cessation in HIV care in India | NIH | National Cancer Institute | 2022 to 2025 | $2,255,431 | September 23, 2021 | August 31, 2027 | KRUSE, GINA RAE | reporter.nih.gov |
| A Randomized Controlled Trial of Exenatide as an Adjunct to Nicotine Patch for Smoking Cessation and Prevention of Post-Cessation Weight Gain | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,246,422 | July 1, 2022 | May 31, 2027 | YAMMINE, LUBA | reporter.nih.gov |
| Using Rural Community Paramedicine to Engage Lower-Motivated Smokers: Spreading an Effective mHealth-Assisted Intervention to Motivate Cessation | NIH | National Cancer Institute | 2022 to 2025 | $2,244,897 | September 5, 2022 | March 31, 2028 | HOUSTON, THOMAS K | reporter.nih.gov |
| Circadian and sleep mechanisms among racial groups for nicotine dependence, craving, and withdrawal | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,240,963 | July 15, 2020 | April 30, 2025 | CROPSEY, KAREN L | reporter.nih.gov |
| Brain and Cognitive Development in the PASS Cohort: The Impact of PrenatalAlcohol Exposure | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,230,991 | September 15, 2017 | June 30, 2028 | SOWELL, ELIZABETH R | reporter.nih.gov |
| PROMINENT - Stanford | NIH | National Cancer Institute | 2022 to 2025 | $2,229,065 | June 22, 2022 | May 31, 2026 | LUNDBERG, EMMA | reporter.nih.gov |
| Administrative Supplement: Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,227,929 | September 1, 2021 | December 31, 2024 | EVINS, A EDEN | reporter.nih.gov |
| Interpeduncular circuitry in stress-responsive behaviors and nicotine dependence | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,222,920 | May 1, 2017 | June 30, 2027 | TAPPER, ANDREW R | reporter.nih.gov |
| Electronic cigarette derived free radicals, oxidative stress and inflammation in lung cancer development | NIH | National Cancer Institute | 2022 to 2025 | $2,222,275 | March 15, 2022 | February 28, 2027 | ZWEIER, JAY LOUIS | reporter.nih.gov |
| Refer 2 Quit: Proactive Promotion of Tobacco Use Treatment for Household Members Who Smoke through Pediatric Primary Care | NIH | National Cancer Institute | 2023 to 2025 | $2,220,666 | September 1, 2023 | August 31, 2028 | JENSSEN, BRIAN P. | reporter.nih.gov |
| Sexual dimorphism in susceptibility to emphysematous tissue injury | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,217,911 | June 1, 2023 | May 31, 2027 | SHIM, YUN MICHAEL | reporter.nih.gov |
| Assessing the Impact of State Preemption Laws | NIH | National Cancer Institute | 2021 to 2025 | $2,213,448 | August 1, 2021 | July 31, 2027 | AZAGBA, SUNDAY | reporter.nih.gov |
| The impact of dyadic processes on smoking and cigarette craving: An experimental investigation of romantic partners and smoking friends | NIH | National Cancer Institute | 2025 | $2,202,321 | August 7, 2025 | July 31, 2029 | SAYETTE, MICHAEL ANDREW | reporter.nih.gov |
| Metabolism Informed Smoking Treatment in Medicaid and Medicare Patients: The MIST RCT | NIH | National Cancer Institute | 2021 to 2023 | $2,201,804 | April 8, 2019 | September 30, 2024 | TINDLE, HILARY A. | reporter.nih.gov |
| Evaluation of the Electronic Cigarette Withdrawal Syndrome: Mechanistic Targets for Intervention | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,193,798 | September 30, 2023 | August 31, 2028 | SPINDLE, TORY RICHARD | reporter.nih.gov |
| Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,189,214 | December 15, 2020 | November 30, 2025 | ROWE, STEVEN MARK | reporter.nih.gov |
| Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care | NIH | National Cancer Institute | 2022 to 2025 | $2,185,542 | July 1, 2022 | June 30, 2028 | CANTRELL, JENNIFER | reporter.nih.gov |
| Prenatal Environmental Mixtures, Cognitive Control and Reward Processes, And Risk for Psychiatric Problems in Adolescence. | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,184,629 | September 1, 2021 | May 31, 2025 | MARGOLIS, AMY | reporter.nih.gov |
| Understanding the clinical pharmacology of marijuana-tobacco co-administration | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,179,609 | May 15, 2023 | February 29, 2028 | ST.HELEN, GIDEON | reporter.nih.gov |
| Role of FABP5 in COPD Exacerbations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,179,399 | June 15, 2019 | June 30, 2028 | GALLY, FABIENNE | reporter.nih.gov |
| Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,172,740 | May 15, 2022 | March 31, 2027 | OLIVER, JASON ANTHONY | reporter.nih.gov |
| Regulatory roles of peptidylarginine deimination in elastogenisis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,172,338 | April 15, 2022 | March 31, 2026 | HO, I-CHENG | reporter.nih.gov |
| Trial of a harm reduction strategy for people with HIV who smoke cigarettes | NIH | National Cancer Institute | 2023 to 2025 | $2,162,300 | May 1, 2023 | April 30, 2028 | SHUTER, JONATHAN | reporter.nih.gov |
| Atherogenic Mechanisms of Electronic Nicotine Delivery Systems | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,160,337 | January 1, 2020 | December 31, 2024 | SRIVASTAVA, SANJAY | reporter.nih.gov |
| Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse? | NIH | National Institute on Drug Abuse | 2022 to 2023 | $2,160,102 | August 1, 2018 | May 31, 2025 | MORRIS, EVAN D | reporter.nih.gov |
| The Mechanistic Impact of Paternal Electronic Nicotine Delivery Systems Exposure on Thrombogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,154,068 | July 1, 2019 | June 30, 2029 | KHASAWNEH, FADI T | reporter.nih.gov |
| Cognitive and Affective Mechanisms Underlying an Olfactory Approach to Modify Cigarette Craving: A Neurobehavioral Investigation | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $2,141,743 | September 21, 2020 | June 30, 2026 | SAYETTE, MICHAEL ANDREW | reporter.nih.gov |
| Effects of chronic marijuana use on endothelial function | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,140,358 | July 1, 2023 | April 30, 2028 | SPRINGER, MATTHEW LAWRENCE | reporter.nih.gov |
| Improving Clinical Trial Efficiency and Quality: Randomized Controlled Evaluations of Remote vs. In-Person Methods | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $2,136,696 | August 1, 2024 | July 31, 2026 | HAWK, LARRY W | reporter.nih.gov |
| Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation | NIH | National Cancer Institute | 2022 to 2024 | $2,125,273 | April 1, 2020 | March 31, 2026 | BRICKER, JONATHAN B | reporter.nih.gov |
| DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCE | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,121,935 | August 15, 2013 | March 31, 2028 | BRUCHAS, MICHAEL R. | reporter.nih.gov |
| Non-Cigarette Tobacco Products as Harm Reduction Tools in Smokers Who Failed to Quit With Traditional Methods | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,120,389 | September 1, 2023 | July 31, 2028 | SMITH, TRACY TAYLOR | reporter.nih.gov |
| Lymphatic Dysfunction in the Pathogenesis of COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,118,673 | April 1, 2023 | January 31, 2028 | REED, HASINA OUTTZ | reporter.nih.gov |
| Cancer prevention through neural and geospatial examination of tobacco marketing effects in smokers | NIH | National Cancer Institute | 2021 to 2023 | $2,107,181 | April 4, 2019 | August 31, 2025 | FALK, EMILY | reporter.nih.gov |
| Resetting the Clock in HIV associated COPD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,102,860 | July 27, 2022 | June 30, 2027 | UNWALLA, HOSHANG JEHANGIR | reporter.nih.gov |
| Airway Basal Progenitor Dysfunction in the Detection, Progression and Pathogenesis of Early COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,100,530 | August 15, 2023 | July 31, 2028 | VANDIVIER, RICHARD W | reporter.nih.gov |
| Characterizing the neural mechanisms of social connection | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,100,133 | April 15, 2022 | January 31, 2027 | DELGADO, MAURICIO R. | reporter.nih.gov |
| Communicating about Nicotine and Differential Risks of Tobacco Products in Priority Populations | NIH | National Cancer Institute | 2021 to 2025 | $2,095,010 | September 16, 2019 | January 31, 2029 | POPOVA, LYUDMILA | reporter.nih.gov |
| Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,078,841 | August 1, 2021 | May 31, 2027 | JAMES, GEORGE ANDREW | reporter.nih.gov |
| Pangenomics of nicotine abuse in the hybrid rat diversity panel | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,073,805 | September 1, 2023 | June 30, 2028 | SHARP, BURT M | reporter.nih.gov |
| TELEhealth Shared decision-making COaching for lung cancer screening in Primary care (TELESCOPE) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,064,881 | April 1, 2022 | March 31, 2027 | KINNEY, ANITA Y. | reporter.nih.gov |
| Early detection and risk of head and neck cancer through immune based spatial omics | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,056,127 | March 1, 2024 | May 31, 2028 | PAI, SARA ISABEL | reporter.nih.gov |
| MAOI-inspired activity probes to translate epigenetics and genetics into drugs | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,049,999 | July 1, 2020 | June 30, 2025 | MATTHEWS, MEGAN L | reporter.nih.gov |
| Randomized clinical trial to test the efficacy of a smartphone app for smoking cessation for nondaily smokers | NIH | National Cancer Institute | 2023 to 2025 | $2,045,275 | August 3, 2023 | July 31, 2028 | HOEPPNER, BETTINA B. | reporter.nih.gov |
| Urban and Reservation Implementation of All Nations Breath of Life to Improve Smoking Cessation Rates among American Indians | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,043,032 | April 1, 2019 | February 28, 2026 | CHOI, WON S | reporter.nih.gov |
| Preclinical Assessment of Medications for Alcohol Abuse | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $2,042,668 | September 28, 2007 | March 31, 2025 | WEERTS, ELISE M | reporter.nih.gov |
| Promoting Equity of Cancer Screening and Follow-up for Lung Cancer. | NIH | National Cancer Institute | 2023 to 2025 | $2,037,945 | June 9, 2023 | May 31, 2028 | DOUBENI, CHYKE ABADAMA | reporter.nih.gov |
| Using Innovative Machine Learning to Detect Organized Support and Opposition to E-cigarette Use Prevention Campaign Messaging on Twitter and TikTok | NIH | National Cancer Institute | 2023 to 2025 | $2,037,391 | July 1, 2023 | June 30, 2028 | FENG, MIAO | reporter.nih.gov |
| Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,034,476 | February 1, 2022 | January 31, 2026 | MCKEON, FRANK D. | reporter.nih.gov |
| Metabolism of Carcinogenic Tobacco-Specific Nitrosamines | NIH | National Cancer Institute | 2021 to 2024 | $2,030,422 | April 1, 1999 | November 30, 2024 | HECHT, STEPHEN S | reporter.nih.gov |
| A smoke-free home intervention in federally subsidized housing | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $2,026,944 | August 15, 2023 | February 29, 2028 | VIJAYARAGHAVAN, MAYA | reporter.nih.gov |
| Vaping Cessation among youth: Evaluating the feasibility and efficacy of a virtual in-person CBT and an app-based CBT4CBT | NIH | National Cancer Institute | 2024 to 2025 | $2,026,668 | September 1, 2024 | August 31, 2029 | KRISHNAN-SARIN, SUCHITRA | reporter.nih.gov |
| Effectiveness of Nicotine Replacement Therapy Sampling in Dental Practices | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2024 | $2,021,888 | August 1, 2020 | July 31, 2025 | JAPUNTICH, SANDRA JANE | reporter.nih.gov |
| Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $2,017,523 | September 13, 2019 | August 31, 2025 | MURFF, HARVEY J. | reporter.nih.gov |
| Mechanisms of nicotine reinforcement | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,016,498 | April 15, 2007 | May 31, 2028 | KENNY, PAUL J. | reporter.nih.gov |
| Ethnic Differences in the Effects of COVID on the Substance Use Behavior of Emerging Adults | NIH | National Institute on Drug Abuse | 2022 to 2024 | $2,014,861 | January 1, 2022 | November 30, 2025 | POKHREL, PALLAV | reporter.nih.gov |
| Optimizing Tobacco Treatment Delivery for People Living with HIV | NIH | National Cancer Institute | 2021 to 2025 | $2,012,292 | March 15, 2021 | February 28, 2027 | ROJEWSKI, ALANA | reporter.nih.gov |
| Intergrating a Smoke-Free Home Intervention into the 5As to Support Cessation | NIH | National Cancer Institute | 2021 to 2024 | $2,010,757 | July 4, 2019 | June 30, 2025 | KEGLER, MICHELLE C | reporter.nih.gov |
| Evaluating Cigarette Relighting Behavior: Prevalence, Correlates, Toxicant Exposure, and Implications for Cessation | NIH | National Cancer Institute | 2023 to 2025 | $1,999,064 | February 15, 2022 | January 31, 2027 | STEINBERG, MICHAEL B. | reporter.nih.gov |
| Communicating Waterpipe Tobacco Harms to Reduce Use among Young Adults | NIH | National Cancer Institute | 2021 to 2024 | $1,996,041 | April 1, 2020 | September 30, 2025 | SUTFIN, ERIN L | reporter.nih.gov |
| A SMART Approach to Treating Tobacco Use Disorder in Persons Living with HIV | NIH | National Cancer Institute | 2021 to 2024 | $1,992,951 | September 19, 2019 | August 31, 2025 | EDELMAN, E. JENNIFER | reporter.nih.gov |
| Assessing Telephone All Nations Breath of Life for Efficacy | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,976,896 | August 1, 2020 | July 31, 2025 | DALEY, SEAN MICHAEL | reporter.nih.gov |
| Financial incentive strategies for smoking cessation in high-risk, hospitalized patients. | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,976,274 | February 15, 2019 | December 31, 2024 | WALI, SOMA | reporter.nih.gov |
| Integrative Characterization on the function of COPD GWAS gene, HHIP | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,966,527 | April 5, 2020 | March 31, 2025 | ZHOU, ANNY XIAOBO | reporter.nih.gov |
| Precision pharmacogenomics and Indigenous research: A novel approach to tobacco cessation efficacy in American Indian communities | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,965,600 | August 15, 2024 | May 31, 2029 | CLAW, KATRINA G | reporter.nih.gov |
| 2/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,960,949 | September 10, 2023 | August 31, 2029 | EHRHARDT, STEPHAN | reporter.nih.gov |
| Contingency Management to Promote Smoking Abstinence in Cancer Patients | NIH | National Cancer Institute | 2021 to 2024 | $1,955,617 | July 7, 2020 | June 30, 2026 | TOLL, BENJAMIN ANDREW | reporter.nih.gov |
| Comparative Modeling of Lung Cancer Prevention, Early Detection and Treatment Interventions | NIH | National Cancer Institute | 2021 to 2022 | $1,950,579 | September 8, 2020 | August 31, 2025 | MEZA, RAFAEL | reporter.nih.gov |
| The Impact of Pharmaceutical Industry Messaging on the Opioid Crisis among U.S. Military Veterans | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,945,365 | May 1, 2023 | February 28, 2028 | HADDOCK, CHRISTOPHER KEITH | reporter.nih.gov |
| Informing ENDS policies: Studying the impact of e-cigarette warnings on behavior | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,943,825 | July 1, 2020 | April 30, 2027 | BREWER, NOEL TODD | reporter.nih.gov |
| Novel modulators of the dopamine transporter for alcohol and nicotine use disorders | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $1,941,979 | September 22, 2016 | March 31, 2026 | BURKLOW, CINDY ANN | reporter.nih.gov |
| The Unvarnished Truth: Pursuing Health Equity by Correcting Disinformation Targeting African Americans about the FDA's Proposed Ban on Menthol Cigarettes and Flavored Cigars | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,940,008 | July 19, 2023 | January 31, 2028 | STERLING, KYMBERLE L | reporter.nih.gov |
| Striatal mechanisms for e-cigarette reinforcement by flavorants | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,939,302 | September 30, 2019 | June 30, 2025 | DE BIASI, MARIELLA | reporter.nih.gov |
| System genetics of menthol and nicotine addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,935,481 | April 1, 2019 | December 31, 2024 | CHEN, HAO | reporter.nih.gov |
| Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks | NIH | National Cancer Institute | 2022 to 2025 | $1,928,268 | March 1, 2022 | February 28, 2027 | MURAMOTO, MYRA L. | reporter.nih.gov |
| Aberrant Micro-managing of the Airway Epithelial Transcriptome in HIV-associated COPD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,926,393 | April 1, 2023 | January 31, 2027 | UNWALLA, HOSHANG JEHANGIR | reporter.nih.gov |
| Anatomical Basis for Nicotine Addiction | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,926,250 | February 1, 2025 | January 31, 2030 | PICCIOTTO, MARINA R | reporter.nih.gov |
| Novel inhibitor for oncogenic RAS for lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,922,100 | March 1, 2021 | June 30, 2026 | PIAZZA, GARY A | reporter.nih.gov |
| Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial | NIH | National Cancer Institute | 2023 to 2025 | $1,920,677 | April 1, 2023 | March 31, 2028 | TAYLOR, KATHRYN L | reporter.nih.gov |
| Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,919,203 | July 6, 2020 | June 30, 2025 | NEPTUNE, ENID R | reporter.nih.gov |
| Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIV | NIH | National Cancer Institute | 2021 to 2024 | $1,907,795 | September 19, 2019 | August 31, 2025 | VIDRINE, DAMON J. | reporter.nih.gov |
| Bupropion for the prevention of postpartum smoking relapse | NIH | National Institute on Drug Abuse | 2022 to 2024 | $1,905,765 | September 30, 2019 | July 31, 2025 | ALLEN, SHARON S | reporter.nih.gov |
| ASSIST: Assessment of Medicaid policy on Smoking Cessation Assistance and Surgical Outcomes | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,901,206 | September 25, 2023 | May 31, 2028 | BAILEY, STEFFANI R | reporter.nih.gov |
| Modeling the impact of age restricted in-person location policies for youth tobacco use | NIH | National Cancer Institute | 2023 to 2025 | $1,898,872 | September 1, 2023 | August 31, 2028 | ROBERTS, MEGAN ELEANOR | reporter.nih.gov |
| A National Test of a Culturally Tailored mHealth Integrated Smoking Cessation and Mental Health Intervention for Black Adults with HIV | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $1,896,151 | September 23, 2024 | June 30, 2029 | GAREY, LORRA | reporter.nih.gov |
| The impact of cannabis and tobacco/nicotine product co-use in young adults: Prospective cessation evaluation and substitution | NIH | National Cancer Institute | 2023 to 2025 | $1,892,323 | September 1, 2023 | August 31, 2028 | MCCLURE, ERIN A | reporter.nih.gov |
| Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation: an RCT | NIH | National Institute on Drug Abuse | 2022 to 2024 | $1,887,323 | May 1, 2022 | March 31, 2028 | PATTEN, CHRISTI A | reporter.nih.gov |
| Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease | NIH | National Cancer Institute | 2021 to 2023 | $1,885,868 | September 2, 2019 | August 31, 2025 | GOLDSTEIN, ADAM O | reporter.nih.gov |
| The Determinants of Tobacco Relapse and Initiation Following a Period of Forced Abstinence in the U.S. Military: A Social Ecological Approach | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,879,969 | May 1, 2018 | December 31, 2024 | LITTLE, MELISSA ASHLEY | reporter.nih.gov |
| Role of FBXO24 mediated ubiquitination of FoxP1 protein in the pathogenesis and treatment of COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,874,669 | July 15, 2020 | June 30, 2025 | CHANDRA, DIVAY | reporter.nih.gov |
| Middle School Cluster RCT to Evaluate E-Cigarette Prevention Program: CATCH My Breath | NIH | National Cancer Institute | 2021 to 2023 | $1,871,876 | May 8, 2019 | April 30, 2025 | KELDER, STEVEN HAROLD | reporter.nih.gov |
| An Improved Epigenetic Algorithm for Guiding Low Dose CT Lung Cancer Screening | NIH | National Cancer Institute | 2023 to 2024 | $1,870,731 | August 1, 2023 | July 31, 2026 | PHILIBERT, ROBERT A | reporter.nih.gov |
| Electronic cigarettes, adolescents, and changes in neurobiology | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,865,875 | May 1, 2021 | March 31, 2027 | HENDERSON, BRANDON JARROD | reporter.nih.gov |
| Mindfulness-based Smoking Cessation Enhanced with Mobile Technology for Low-Income Smokers | NIH | National Cancer Institute | 2021 to 2023 | $1,864,511 | May 1, 2019 | April 30, 2025 | SPEARS, CLAIRE ADAMS | reporter.nih.gov |
| Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,859,561 | July 1, 2019 | June 30, 2025 | HENDRICKS, PETER S. | reporter.nih.gov |
| Assessing the integration of tobacco cessation treatment into lung cancer screening | NIH | National Cancer Institute | 2021 to 2022 | $1,854,490 | April 16, 2018 | March 31, 2024 | PARK, ELYSE R. | reporter.nih.gov |
| ENDS use trajectories from adolescence through young adulthood: A longitudinal study of risk factors and profiles | NIH | National Cancer Institute | 2021 to 2023 | $1,853,716 | February 15, 2019 | January 31, 2025 | HARRELL, MELISSA BLYTHE | reporter.nih.gov |
| Role of E-cadherin in modulating airway epithelial function and parenchymal remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,834,908 | April 5, 2020 | March 31, 2024 | SIDHAYE, VENKATARAMANA K | reporter.nih.gov |
| Comparative Effectiveness of Sequential Pharmacotherapeutic Strategies and Virtually Delivered Treatment to Optimize Smoking Cessation | NIH | National Cancer Institute | 2024 to 2025 | $1,834,300 | January 1, 2024 | December 31, 2028 | ROBINSON, JASON D | reporter.nih.gov |
| Validation of the TAPS-Electronic Spanish Platform (TAPS-ESP): A Technology to Improve Access to Substance Use Screening and Reduce Behavioral Health Disparities in Hispanic Primary Care Patients | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $1,833,979 | September 19, 2018 | May 31, 2025 | CARSWELL, STEVEN BERNARD | reporter.nih.gov |
| Mechanisms of DNA damage induced emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,827,951 | July 15, 2014 | May 31, 2025 | ARMANIOS, MARY Y | reporter.nih.gov |
| Linking brain network dynamics to imminent smoking lapse risk and behavior | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,827,302 | September 30, 2022 | July 31, 2027 | WILSON, STEPHEN JEFFREY | reporter.nih.gov |
| 1/2 Multi-Center CLEAN AIR 2 Randomized Control Trial in COPD | NIH | National Heart, Lung, and Blood Institute | 2023 | $1,826,564 | September 10, 2023 | August 31, 2024 | HANSEL, NADIA N | reporter.nih.gov |
| Examining nicotine relapse in the habenulo-interpeduncular system | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,816,344 | August 1, 2016 | March 31, 2027 | DRENAN, RYAN MICHAEL | reporter.nih.gov |
| Targeting Underlying Pathophysiological Mechanisms to Develop Novel Therapies for Chronic Obstructive Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,814,231 | November 11, 2022 | May 31, 2026 | ZAHID, MALIHA | reporter.nih.gov |
| A clinical trial of adaptive treatment for early smoking cessation relapse | NIH | National Cancer Institute | 2023 to 2025 | $1,800,850 | July 1, 2023 | June 30, 2028 | SMITH, TRACY TAYLOR | reporter.nih.gov |
| Predictors and Consequences of Nicotine and Cannabis Vaping Co-use in Young Adults: A Longitudinal and EMA Analysis | NIH | National Cancer Institute | 2021 to 2025 | $1,795,774 | April 1, 2021 | March 31, 2027 | DUNBAR, MICHAEL | reporter.nih.gov |
| Kidney DNA Adductomics | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $1,780,039 | August 7, 2020 | May 31, 2026 | TURESKY, ROBERT J. | reporter.nih.gov |
| Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,777,294 | August 1, 2023 | May 31, 2028 | PERSIDSKY, YURI | reporter.nih.gov |
| Clinical implications and Proteomics of Bronchiectasis Progression in Smokers | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,760,335 | May 15, 2024 | February 29, 2028 | DIAZ, ALEJANDRO | reporter.nih.gov |
| The role of epigenetics in RPE heterogeneity with early AMD | NIH | National Eye Institute | 2022 to 2025 | $1,750,941 | June 1, 2022 | May 31, 2026 | HANDA, JAMES T | reporter.nih.gov |
| Genetic variants that affect the airway epithelium to drive obstructive lung disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,748,401 | April 1, 2024 | March 31, 2028 | TESFAIGZI, YOHANNES | reporter.nih.gov |
| Early Intervention to Promote Cardiovascular Health of Mothers and Children in Northern Appalachia | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,745,362 | May 5, 2022 | June 30, 2029 | PAUL, IAN M | reporter.nih.gov |
| Multilevel Determinants of Differences in Lung Cancer Screening Utilization | NIH | National Cancer Institute | 2022 to 2025 | $1,738,430 | June 7, 2022 | April 30, 2027 | SAKODA, LORI | reporter.nih.gov |
| Dual Use Cessation: A MOST Screening Trial to Identify Effective Interventions to Help People Who Smoke and Vape | NIH | National Cancer Institute | 2024 to 2025 | $1,732,485 | May 1, 2024 | April 30, 2029 | PIPER, MEGAN E | reporter.nih.gov |
| Biological impact of exclusive and dual e-cigarette use on oral cancer risk | NIH | National Cancer Institute | 2021 to 2024 | $1,730,250 | July 15, 2020 | June 30, 2026 | QUEIMADO, LURDES | reporter.nih.gov |
| Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV | NIH | National Cancer Institute | 2021 to 2025 | $1,727,341 | September 19, 2019 | February 28, 2027 | CROTHERS, KRISTINA ANNE | reporter.nih.gov |
| Assessing the impact and mechanisms of a novel policy intervention to reduce tobacco retailer density in communities | NIH | National Cancer Institute | 2023 to 2025 | $1,720,928 | February 1, 2023 | January 31, 2028 | GIOVENCO, DANIEL PHILIP | reporter.nih.gov |
| Informing anti-tobacco communications with affective and decision science: Application of the Appraisal Tendency Framework | NIH | National Cancer Institute | 2021 to 2023 | $1,720,766 | September 17, 2019 | August 31, 2025 | REES, VAUGHAN W. | reporter.nih.gov |
| Sustainability of Tobacco Cessation Programs at NCI-Designated Cancer Centers | NIH | National Cancer Institute | 2023 to 2025 | $1,719,616 | July 1, 2023 | June 30, 2028 | SALLOUM, RAMZI GEORGE | reporter.nih.gov |
| E-Cigarette Vaping during Pregnancy and Lactation, Germ Cell Epigenetic Memory, and Transgenerational Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,694,775 | June 1, 2020 | May 31, 2025 | REHAN, VIRENDER K | reporter.nih.gov |
| Remote, Young Adult Lay-Counselor Delivered Behavioral and Digital Intervention for Youth to Promote Vaping Cessation and Prevent Escalation of Tobacco Use | NIH | National Cancer Institute | 2024 to 2025 | $1,694,194 | September 6, 2024 | August 31, 2029 | EVINS, A EDEN | reporter.nih.gov |
| The Positively Quit Trial: Addressing disproportionate smoking rates among people living with HIV | NIH | National Cancer Institute | 2021 to 2024 | $1,686,890 | August 1, 2019 | July 31, 2025 | MARHEFKA, STEPHANIE LYNN | reporter.nih.gov |
| Prevalence and Clinical Correlates of Thirdhand Smoke Exposure in a Pediatric Patient Population | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,685,039 | August 15, 2019 | July 31, 2025 | MAHABEE-GITTENS, E. MELINDA | reporter.nih.gov |
| Cytoprotective pathways in esophageal squamous epithelia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,673,359 | July 15, 2023 | May 31, 2027 | KATZ, JONATHAN P | reporter.nih.gov |
| Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot | NIH | National Institute on Aging | 2021 | $1,647,910 | September 15, 2017 | November 30, 2023 | YAFFE, KRISTINE | reporter.nih.gov |
| Molecular and Cellular Pathogenesis of Pulmonary Langerhans Cell Histiocytosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,640,572 | May 1, 2023 | April 30, 2027 | BORCHERS, MICHAEL | reporter.nih.gov |
| DNA Repair Capacity Assays for Lung Disease Risk Assessment | NIH | National Cancer Institute | 2021 to 2022 | $1,638,124 | September 1, 2018 | August 31, 2024 | BELINSKY, STEVEN A | reporter.nih.gov |
| Smartphone Based Smoking Cessation Intervention for Socioeconomically Disadvantaged Adults | NIH | National Cancer Institute | 2021 to 2023 | $1,634,159 | February 1, 2019 | January 31, 2025 | BUSINELLE, MICHAEL S. | reporter.nih.gov |
| Financial incentives for homeless smokers: A community-based RCT | NIH | National Cancer Institute | 2021 to 2024 | $1,630,201 | April 1, 2019 | May 31, 2025 | BAGGETT, TRAVIS P. | reporter.nih.gov |
| Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia | NIH | National Cancer Institute | 2023 to 2025 | $1,619,050 | February 1, 2023 | January 31, 2028 | BERG, CARLA J | reporter.nih.gov |
| Evaluation of cigarette package inserts for enhanced communication with smokers | NIH | National Cancer Institute | 2021 to 2024 | $1,617,411 | January 15, 2019 | December 31, 2025 | THRASHER, JAMES | reporter.nih.gov |
| Utility of adaptive design optimization for developing rapid and reliable behavioral paradigms for substance use disorders | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,612,827 | September 1, 2023 | June 30, 2028 | VASSILEVA, JASMIN L | reporter.nih.gov |
| Implementation science to scale and sustain tobacco treatment leveraging point of care paradigm and health information technology | NIH | National Cancer Institute | 2025 | $1,594,797 | September 4, 2025 | August 31, 2027 | CHEN, LI-SHIUN | reporter.nih.gov |
| Phase 2 study examining efficacy and mechanisms of combining varenicline and guanfacine for smoking cessation in women and men | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,590,060 | June 15, 2020 | April 30, 2025 | MCKEE, SHERRY ANN | reporter.nih.gov |
| Alveolar epithelial cell dysfunction induced by flavored e-cigarette aerosols | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $1,582,924 | September 10, 2020 | August 31, 2025 | KOSMIDER, BEATA | reporter.nih.gov |
| Gene-environment interaction pathways in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,581,271 | April 9, 2019 | February 28, 2025 | HOLOSHITZ, JOSEPH | reporter.nih.gov |
| COPD GWAS Functional Variant Identification in Airway Epithelial Cells using Deep Learning Splicing Models | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,570,184 | August 1, 2024 | May 31, 2028 | CASTALDI, PETER | reporter.nih.gov |
| Actívatexto: Advancing smoking cessation and physical activity among Latinos | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $1,564,544 | September 20, 2024 | May 31, 2029 | CARTUJANO, FRANCISCO | reporter.nih.gov |
| Extensions of Mendelian Randomization Methodology for Combined Genomic and Methylomic Analysis | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,550,364 | July 1, 2020 | May 31, 2025 | NEALE, MICHAEL CHURTON | reporter.nih.gov |
| Evaluating the role of epithelial basal cells in laryngeal homeostasis and disease development | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $1,549,955 | June 1, 2022 | May 31, 2027 | DIRENZO, ELIZABETH | reporter.nih.gov |
| ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,549,914 | September 15, 2022 | November 30, 2024 | HEFFNER, JAIMEE | reporter.nih.gov |
| Understanding determinants of racial disparities in lung cancer incidence | NIH | National Cancer Institute | 2021 to 2023 | $1,548,066 | May 7, 2020 | April 30, 2025 | ALDRICH, MELINDA | reporter.nih.gov |
| Benzene exposure promotes neuroinflammation and metabolic dysregulation | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $1,536,687 | April 1, 2022 | January 31, 2027 | SADAGURSKI, MARIANNA | reporter.nih.gov |
| Experimentally Testing Legally Feasible Regulatory Options for Reducing the Impact of the Point-of-sale Retail Environment on Adolescent Tobacco Use. | NIH | National Cancer Institute | 2021 to 2023 | $1,525,985 | April 9, 2019 | March 31, 2025 | SHADEL, WILLIAM G | reporter.nih.gov |
| Developing a novel agonist of CD137 for cancer immunoprevention | NIH | National Cancer Institute | 2024 to 2025 | $1,522,188 | July 17, 2024 | May 31, 2026 | SHIRWAN, HAVAL | reporter.nih.gov |
| Assessment of a Digitally Controlled Aerosolized Nicotine Replacement Therapy | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,518,273 | May 1, 2024 | April 30, 2027 | DAVIS, JAMES M | reporter.nih.gov |
| Nicotine and NLRP3 Inflammasome in HIV-1-Associated CNS Inflammation | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,517,460 | May 15, 2024 | February 28, 2029 | SWARTZ, TALIA H | reporter.nih.gov |
| Biomarker phenotypes of air pollution and cancer risk in India | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,516,120 | September 23, 2021 | June 30, 2027 | STEPANOV, IRINA | reporter.nih.gov |
| Translational regulation during cigarette smoking-induced reprogramming of the tRNA epitranscriptome, in vitro and in a mouse smoking model | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $1,511,960 | June 9, 2020 | March 31, 2026 | BEGLEY, THOMAS J | reporter.nih.gov |
| Evaluating the Effect of E-cigarette Policies on Youth Tobacco Use | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,505,501 | June 1, 2018 | June 30, 2027 | PESKO, MICHAEL | reporter.nih.gov |
| Gene Regulation in Memory Circuits as a Consequence of Polysubstance Use | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,500,894 | August 1, 2023 | June 30, 2028 | KAUN, KARLA R. | reporter.nih.gov |
| Postdoctoral training in tobacco control | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,500,089 | July 1, 2023 | June 30, 2028 | LING, PAMELA MAY | reporter.nih.gov |
| The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,496,060 | February 14, 2011 | December 31, 2025 | HAYES, RICHARD BERNARD | reporter.nih.gov |
| Dissolved Phase Hyperpolarized Xenon-129 MRI: a novel biomarker to quantify pulmonary pathology in young healthy e-cigarette users | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,493,710 | July 15, 2024 | April 30, 2029 | SHIM, YUN MICHAEL | reporter.nih.gov |
| Protective effects of metformin against cigarette smoke-induced lung pathologies via regulation of fatty acids metabolism | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,492,860 | August 1, 2024 | July 31, 2028 | POLVERINO, FRANCESCA | reporter.nih.gov |
| Deep TMS Neuromodulation of Neural Circuits Associated with Stimulant Use Disorder | NIH | National Institute on Drug Abuse | 2024 | $1,491,755 | September 15, 2024 | August 31, 2026 | PADULA, CLAUDIA B. | reporter.nih.gov |
| A Pathogenic Smoke Associated Neutrophilic Exosomal Pathway. | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,485,000 | May 1, 2022 | April 30, 2027 | GENSCHMER, KRISTOPHER R. | reporter.nih.gov |
| Effects of State Preemption of Local Tobacco Control Legislation on Disparities in Tobacco Use, Exposure and Retail | NIH | National Cancer Institute | 2023 to 2025 | $1,484,132 | April 15, 2023 | March 31, 2027 | YANG, Y. TONY | reporter.nih.gov |
| P. gingivalis genes essential for tobacco smoke survival | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,474,413 | September 1, 2017 | June 30, 2026 | SCOTT, DAVID A | reporter.nih.gov |
| Testing the impact of smartphone-based messaging to support young adult smoking cessation | NIH | National Cancer Institute | 2021 to 2025 | $1,467,652 | September 1, 2020 | May 31, 2027 | THRUL, JOHANNES | reporter.nih.gov |
| Understanding lung cancer genomics in patients of African ancestry | NIH | National Cancer Institute | 2024 to 2025 | $1,460,798 | July 1, 2024 | June 30, 2026 | CARROT-ZHANG, JIAN | reporter.nih.gov |
| Adolescent Exposure to Stress or Nicotine Increases Rodent Alcohol Self-Administration | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $1,460,745 | August 10, 2019 | July 31, 2025 | DANI, JOHN A. | reporter.nih.gov |
| The role of familiarity neurocircuitry in novelty seeking | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,460,691 | August 1, 2019 | May 31, 2025 | TAPPER, ANDREW R | reporter.nih.gov |
| Regulatory Impact on Vape Shops and Young Adults' Use of ENDS | NIH | National Cancer Institute | 2021 to 2022 | $1,452,934 | August 1, 2019 | November 30, 2023 | BERG, CARLA J | reporter.nih.gov |
| Selective Positive Allosteric Modulators of a4b2 Nicotinic Receptors | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,444,227 | August 1, 2024 | May 31, 2029 | THAKUR, GANESH A | reporter.nih.gov |
| The Houston ECHO Pregnancy Cohort Study Site | NIH | Office of the Director, National Institutes of Health | 2025 | $1,444,117 | September 1, 2023 | May 31, 2030 | WHITWORTH, KRISTINA WALKER | reporter.nih.gov |
| Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,438,354 | January 15, 2024 | December 31, 2027 | SERBAN, KARINA | reporter.nih.gov |
| Predicting Effects of ENDS Flavor Regulations on Tobacco Behavior, Toxicity, and Abuse Liability among African American Menthol Smokers | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,437,754 | July 1, 2021 | June 30, 2024 | COBB, CAROLINE O | reporter.nih.gov |
| Non-hormonal function of locally delivered PTH for rescue of impaired fracture healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,428,879 | February 1, 2019 | January 31, 2026 | LEE, FRANCIS YOUNG-IN | reporter.nih.gov |
| Mechanisms of cancer mutations | NIH | National Cancer Institute | 2023 to 2025 | $1,423,519 | December 1, 2022 | November 30, 2027 | PFEIFER, GERD P | reporter.nih.gov |
| Individualizing pharmacotherapy: A novel optimization strategy to increase smoking cessation in the African American community. | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,423,058 | July 1, 2018 | April 30, 2024 | NOLLEN, NICOLE L | reporter.nih.gov |
| Early Intervention to Promote Cardiovascular Health of Mothers and Children in Northern Appalachia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,421,244 | May 5, 2022 | June 30, 2024 | PAUL, IAN M | reporter.nih.gov |
| Optimizing Tobacco Treatment for Smokers Seeking Lung Cancer Screening | NIH | National Cancer Institute | 2021 to 2022 | $1,416,144 | August 9, 2016 | November 30, 2023 | OSTROFF, JAMIE S. | reporter.nih.gov |
| Harm Reduction for Smokers with Mental Illness: RCT of E-cigarette Provision with or without Behavioral Support to Boost Switching | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,413,427 | June 1, 2024 | March 31, 2028 | PRATT, SARAH ILANA | reporter.nih.gov |
| Improving risk stratification for lung cancer screening using peripheral blood leukocyte DNA methylation: an investigation in the National Lung Screening Trial (NLST) | NIH | National Cancer Institute | 2024 to 2025 | $1,398,708 | March 1, 2024 | February 28, 2028 | MICHAUD, DOMINIQUE S. | reporter.nih.gov |
| A Multivariate Mediation and Deep Learning Framework for Genome-Connectome -Substance Use Research | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,390,500 | September 1, 2019 | August 31, 2025 | CHEN, SHUO | reporter.nih.gov |
| RTMS manipulates imbalanced drive-reward and executive control circuitry for smoking cessation | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,383,184 | March 1, 2024 | February 28, 2027 | LI, XINGBAO | reporter.nih.gov |
| Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol use among PWH in Nairobi, Kenya | NIH | National Cancer Institute | 2024 to 2025 | $1,382,393 | September 18, 2024 | August 31, 2029 | HIMELHOCH, SETH S | reporter.nih.gov |
| Effectiveness of a smoking cessation algorithm integrated into HIV primary care | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,380,640 | September 30, 2018 | June 30, 2025 | CROPSEY, KAREN L | reporter.nih.gov |
| Social media support groups for adolescent vaping cessation | NIH | National Cancer Institute | 2024 to 2025 | $1,369,690 | September 9, 2024 | August 31, 2029 | LING, PAMELA MAY | reporter.nih.gov |
| Dihydroxyacetone exposure induces metabolic reprogramming and mitochondrial dysfunction | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $1,361,876 | November 19, 2021 | October 31, 2025 | GASSMAN, NATALIE ROSE | reporter.nih.gov |
| ELECTRONIC CIGARETTE VAPING & VASCULAR SEQUELAE IN THE UTERUS DURING PREGNANCY. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,359,726 | January 5, 2021 | December 31, 2025 | RAMADOSS, JAYANTH | reporter.nih.gov |
| A Translational Randomized Clinical Trial of Varenicline Sampling to Promote Smoking Cessation and Scalable Treatment Dissemination | NIH | National Cancer Institute | 2021 to 2024 | $1,349,420 | July 8, 2020 | June 30, 2025 | CARPENTER, MATTHEW J | reporter.nih.gov |
| PROMINENT - IARC | NIH | National Cancer Institute | 2022 to 2024 | $1,345,330 | June 22, 2022 | May 31, 2025 | BRENNAN, PAUL JOSEPH | reporter.nih.gov |
| DNA adductome of human bladder from the tobacco exposome | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,342,122 | April 1, 2019 | December 31, 2024 | TURESKY, ROBERT J. | reporter.nih.gov |
| Effect of Cannabinoids on Tobacco Product Demand and Pharmacodynamics | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,337,048 | May 1, 2024 | February 28, 2029 | LEE, DUSTIN CLARK | reporter.nih.gov |
| Integrative, age-related changes in genome and epigenome in human lung in relation to smoking | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,327,731 | January 1, 2019 | December 31, 2023 | SPIVACK, SIMON D | reporter.nih.gov |
| Health effects of cannabidiol vaping products | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,323,987 | March 1, 2024 | December 31, 2027 | REBULI, MEGHAN ELIZABETH | reporter.nih.gov |
| Achieving smoking cessation milestones in opioid treatment patients: a randomized 2 x 2 factorial trial of directly observed and long-term varenicline | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,323,884 | April 1, 2017 | November 30, 2024 | NAHVI, SHADI | reporter.nih.gov |
| Assessing genome sequence integrity in normal human cells | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,323,174 | August 15, 2018 | May 31, 2023 | VIJG, JAN | reporter.nih.gov |
| Evaluating implementation of Tobacco 21 laws in the U.S. | NIH | National Cancer Institute | 2022 to 2025 | $1,316,352 | July 1, 2018 | December 31, 2029 | HRYWNA, MARIA | reporter.nih.gov |
| Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking: A Randomized Controlled Trial | NIH | National Cancer Institute | 2024 to 2025 | $1,314,571 | September 1, 2024 | August 31, 2029 | MCCLURE, JENNIFER B | reporter.nih.gov |
| Testing Oral Nicotine Pouches to Reduce Smoking-Related Cancer Disparities in Appalachia | NIH | National Cancer Institute | 2024 to 2025 | $1,311,113 | September 4, 2024 | August 31, 2029 | KELLER-HAMILTON, BRITTNEY L | reporter.nih.gov |
| Sequencing Familial Lung Cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,309,253 | January 22, 2020 | December 31, 2024 | AMOS, CHRISTOPHER I. | reporter.nih.gov |
| Nicotinic acetylcholine receptor function in the mesolimbic dopamine system | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,307,948 | August 1, 2014 | May 31, 2025 | DRENAN, RYAN MICHAEL | reporter.nih.gov |
| Dual use of combustible and electronic cigarettes: A fine-grained naturalistic cohort study to investigate dynamic use patterns and trajectories that lead to smoking cessation | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,306,268 | July 1, 2024 | April 30, 2029 | CARPENTER, MATTHEW J | reporter.nih.gov |
| Scaling up tobacco control in India: Comparing smartphone to in-person training for implementing an evidence-based intervention to reduce tobacco use among schoolteachers | NIH | National Cancer Institute | 2021 to 2024 | $1,305,092 | September 1, 2021 | July 31, 2025 | NAGLER, EVE M | reporter.nih.gov |
| Psychopharmacological effects of cannabidiol on responses to stress and nicotine withdrawal | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,303,839 | September 30, 2010 | February 28, 2029 | AL'ABSI, MUSTAFA | reporter.nih.gov |
| Effects of marijuana use on inflammation and vascular injury in adults with HIV infection | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,297,182 | April 1, 2018 | February 28, 2025 | GABUZDA, DANA H. | reporter.nih.gov |
| Implementing A Virtual Tobacco Treatment in Community Oncology Practices | NIH | National Cancer Institute | 2021 to 2023 | $1,296,965 | February 1, 2018 | July 31, 2024 | PARK, ELYSE R. | reporter.nih.gov |
| Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV | NIH | National Cancer Institute | 2024 to 2025 | $1,294,796 | February 9, 2024 | January 31, 2029 | VILARDAGA, ROGER | reporter.nih.gov |
| Implementing Sustainable mobile health Technology to Optimize smoking cessation Program for Lao people with HIV (I-STOP) | NIH | National Cancer Institute | 2024 to 2025 | $1,292,796 | August 12, 2024 | July 31, 2029 | BUI, THANH C. | reporter.nih.gov |
| Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,283,356 | September 30, 2018 | July 31, 2025 | WITWER, KENNETH W | reporter.nih.gov |
| Evaluating a tobacco harm reduction strategy among clients enrolled in substance use disorder treatment | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,283,188 | September 15, 2024 | May 31, 2029 | MCCLURE, ERIN A | reporter.nih.gov |
| Tobacco retail policy innovation to reduce health disparities | NIH | National Cancer Institute | 2021 to 2022 | $1,278,681 | September 20, 2019 | October 31, 2024 | MALONE, RUTH E | reporter.nih.gov |
| Neural mechanisms mediating appetitive regulation and smoking in nicotine addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,278,428 | August 8, 2020 | March 31, 2026 | FROELIGER, BRETT | reporter.nih.gov |
| Population Health Management Approaches to Increase Lung Cancer Screening in Community Health Centers | NIH | National Cancer Institute | 2024 to 2025 | $1,278,190 | May 15, 2024 | April 30, 2026 | WETTER, DAVID W | reporter.nih.gov |
| Gene-tobacco carcinogen interactions and lung cancer risk - a novel approach for precision cancer prevention | NIH | National Cancer Institute | 2023 to 2024 | $1,273,289 | December 16, 2022 | July 15, 2024 | LAZARUS, PHILIP | reporter.nih.gov |
| Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers | NIH | National Cancer Institute | 2024 to 2025 | $1,270,404 | April 1, 2024 | March 31, 2028 | AUDRAIN-MCGOVERN, JANET E | reporter.nih.gov |
| Motivational interviewing and air cleaners for smokers with COPD (MOVE COPD) | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,269,855 | September 15, 2018 | May 31, 2025 | HANSEL, NADIA N | reporter.nih.gov |
| Neurodevelopmental Effects of Prenatal Exposure to Maternal Drinking, Smoking and Adverse Psychosocial Factors: Deep Phenotyping of Infant CNS and ANS Function | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2024 | $1,266,776 | April 1, 2022 | March 31, 2026 | FIFER, WILLIAM P. | reporter.nih.gov |
| Sequencing Familial Lung Cancer | NIH | National Cancer Institute | 2023 to 2024 | $1,265,253 | January 22, 2020 | June 30, 2025 | LIU, YANHONG | reporter.nih.gov |
| Does age/stress-induced mitochondrial dysfunction induce variations in RPE phenotype in AMD? | NIH | National Eye Institute | 2024 to 2025 | $1,262,105 | March 1, 2024 | December 31, 2028 | WANG, SHUSHENG | reporter.nih.gov |
| Leveraging epidemiological data to inform the development of a just-in-time adaptive intervention for young adults co-using e-cigarettes and cannabis | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,258,187 | April 1, 2024 | March 31, 2026 | PHILLIPS, KRISTINA T. | reporter.nih.gov |
| Using a Pragmatic Randomized Rollout Trial to Evaluate Implementation Strategies to Promote Smoking Treatment and Cancer Prevention for Salvation Army Clients | NIH | National Cancer Institute | 2024 to 2025 | $1,257,359 | September 15, 2024 | August 31, 2026 | MCCARTHY, DANIELLE ERIN | reporter.nih.gov |
| Habenula Circuitry, Smoking, and Genomics | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,257,252 | September 30, 2024 | May 31, 2027 | LONDON, EDYTHE DANICK | reporter.nih.gov |
| Adrenomedullin Signaling at the Maternal-Fetal Interface | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,252,975 | April 1, 2009 | January 31, 2028 | CARON, KATHLEEN M | reporter.nih.gov |
| Optimizing smoking cessation interventions for PLWH in Nairobi, Kenya | NIH | National Cancer Institute | 2021 to 2022 | $1,252,511 | September 5, 2018 | August 31, 2024 | HIMELHOCH, SETH S | reporter.nih.gov |
| Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens | NIH | National Cancer Institute | 2021 to 2022 | $1,252,043 | August 3, 2018 | July 31, 2024 | HECHT, STEPHEN S | reporter.nih.gov |
| Electronic Cigarettes During Pregnancy: Impact on Fetal Development | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,248,751 | August 15, 2018 | May 31, 2026 | STROUD, LAURA R | reporter.nih.gov |
| Program on Occupational Health and Safety Education on Emerging Technologies - Mid Atlantic Partnership (POccET MAP) | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,247,726 | September 1, 2021 | August 31, 2026 | RAMACHANDRAN, GURUMURTHY | reporter.nih.gov |
| Intergenerational Studies Consortium: Understanding Mechanisms of Family Substance Use Transmission and Effects of Marijuana Legalization | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,235,266 | June 20, 2003 | May 31, 2024 | CAPALDI, DEBORAH M. | reporter.nih.gov |
| The role of flavor in the substitutability of e-cigarettes for combustible cigarettes among persistent smokers | NIH | National Cancer Institute | 2024 to 2025 | $1,231,322 | January 17, 2024 | December 31, 2027 | AUDRAIN-MCGOVERN, JANET E | reporter.nih.gov |
| Predicting Sleep, Smoking and Lung Health Disparities in at-risk Black African American Adults | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $1,225,354 | April 1, 2018 | November 30, 2023 | SATTI, ADITI GHATGE | reporter.nih.gov |
| Methodology and measurement for examining short-term and long-term effects of e-cigarette and polysubstance use | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,225,312 | August 15, 2019 | December 31, 2024 | BUU, YUH-PEY ANNE | reporter.nih.gov |
| Randomized Clinical Trial of a Culturally-Tailored Suite of Smoking Cessation Resources for American Indian Persons | NIH | National Cancer Institute | 2024 to 2025 | $1,219,289 | September 20, 2024 | August 31, 2029 | CARROLL, DANA MOWLS | reporter.nih.gov |
| Intrauterine exposure to tobacco smoke, DNA methylation, and vision disorders in preschool children | NIH | National Eye Institute | 2021 to 2023 | $1,212,750 | September 1, 2019 | July 31, 2025 | JIANG, XUEJUAN | reporter.nih.gov |
| Genetic modifiers of Chrna5 deletion in mice: role in nicotine behaviors modulated by the medial habenula-IPN pathway | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,212,285 | April 1, 2018 | December 31, 2023 | STITZEL, JERRY A | reporter.nih.gov |
| Leveraging Community-Engaged Research to Co-Create Youth Vaping Prevention with Urban Indigenous Communities of the Southwest | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,211,365 | September 1, 2024 | May 31, 2029 | VOLLRATH, STEPHANIE AYERS | reporter.nih.gov |
| Scaling Up Community-based Noncommunicable Disease Research into Practice in Pokhara Metropolitan City of Nepal (SCALE-NCD) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,209,569 | March 1, 2024 | February 28, 2029 | NEUPANE, DINESH | reporter.nih.gov |
| Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings | NIH | National Cancer Institute | 2023 to 2025 | $1,205,344 | September 20, 2023 | May 31, 2027 | GUERRERO-PRESTON, RAFAEL | reporter.nih.gov |
| Contribution of Thirdhand Smoke to Overall Tobacco Smoke Exposure in Pediatric Patients | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,205,297 | January 1, 2018 | December 31, 2024 | MAHABEE-GITTENS, E. MELINDA | reporter.nih.gov |
| Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening | NIH | National Cancer Institute | 2021 to 2023 | $1,205,296 | July 15, 2020 | June 30, 2025 | HENDERSON, LOUISE | reporter.nih.gov |
| Affective science and smoking cessation: Real time real world assessment | NIH | National Cancer Institute | 2021 to 2023 | $1,204,308 | January 19, 2018 | December 31, 2024 | LAM, CHO YAN | reporter.nih.gov |
| Randomized controlled trial of varenicline to treat tobacco and cannabis co-use. | NIH | National Cancer Institute | 2024 to 2025 | $1,201,687 | June 1, 2024 | May 31, 2026 | MCCLURE, ERIN A | reporter.nih.gov |
| Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood Management | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,193,451 | August 18, 2017 | April 30, 2025 | BUSCH, ANDREW M | reporter.nih.gov |
| Novel, On-demand VR for Accessible, Practical, and Engaging therapy (NO VAPE) | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,187,571 | September 1, 2023 | February 28, 2026 | BRACKEN, BETHANY K | reporter.nih.gov |
| TAAR1 agonists for nicotine addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,184,734 | April 1, 2019 | February 28, 2025 | LI, JUN-XU | reporter.nih.gov |
| Differentiating the biological effects of vaping from smoking by analyzing the methylome and transcriptome | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $1,184,550 | August 15, 2023 | May 31, 2028 | BESARATINIA, AHMAD | reporter.nih.gov |
| Role of TACC2 in smoking-induced COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,181,575 | February 15, 2020 | December 31, 2024 | NYUNOYA, TORU | reporter.nih.gov |
| A Text-Based Scheduled Reduction Intervention for Smokeless Tobacco Cessation | NIH | National Cancer Institute | 2021 to 2023 | $1,177,998 | September 1, 2019 | August 31, 2025 | NOONAN, DEVON | reporter.nih.gov |
| Defining and targeting mechanisms of smoke-mediated fibrosis progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,177,500 | April 1, 2019 | March 31, 2026 | CHEN, CHING-HSIEN | reporter.nih.gov |
| Habenular immune signaling and addiction | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,177,432 | September 30, 2018 | June 30, 2023 | KENNY, PAUL J. | reporter.nih.gov |
| Behavioral Intervention to Mitigate Nicotine Addiction in Digital Environments | NIH | National Cancer Institute | 2024 to 2025 | $1,173,064 | April 3, 2024 | March 31, 2029 | POPOVA, LYUDMILA | reporter.nih.gov |
| Early life exposures and chronic lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,170,000 | April 1, 2020 | February 28, 2025 | ROMAN, JESSE | reporter.nih.gov |
| Elucidating Mechanisms of Pregnancy's Protective Effect on Drug Abuse Using Integrated Data Analysis | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,169,721 | March 1, 2021 | November 30, 2022 | MASSEY, SUENA HUANG | reporter.nih.gov |
| Neuroinflammatory and glutamatergic mechanisms of nicotine seeking | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,168,759 | September 1, 2020 | August 31, 2025 | GIPSON-REICHARDT, CASSANDRA D | reporter.nih.gov |
| Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity | NIH | National Cancer Institute | 2023 to 2025 | $1,164,631 | July 3, 2023 | June 30, 2029 | SMITS, JASPER | reporter.nih.gov |
| Impacts of Neighborhood Contexts and Medicaid Policy on Lung Cancer Survival in Low-SES Patients | NIH | National Cancer Institute | 2022 to 2025 | $1,163,207 | July 15, 2022 | June 30, 2027 | LIU, YING | reporter.nih.gov |
| Advancing VR-based attentional bias as a biomarker for tobacco use disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,161,496 | August 15, 2024 | May 31, 2028 | COURTNEY, KELLY ELIZABETH | reporter.nih.gov |
| Inflammasome and unstable atherosclerotic plaques | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,159,951 | September 1, 2008 | April 30, 2023 | ZOU, MING-HUI | reporter.nih.gov |
| Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational Studies | NIH | National Cancer Institute | 2021 to 2024 | $1,157,605 | April 1, 2013 | January 31, 2026 | EL-BAYOUMY, KARAM E | reporter.nih.gov |
| Policy Change and Women's Health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,145,664 | June 15, 2019 | May 31, 2025 | MARGERISON, CLAIRE E | reporter.nih.gov |
| Neural Substrates of Cigarette Craving, Withdrawal, and Relief: Male-Female Differences | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,141,524 | September 1, 2017 | August 31, 2023 | LONDON, EDYTHE DANICK | reporter.nih.gov |
| Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,135,235 | September 1, 2014 | May 31, 2024 | TSOH, JANICE Y | reporter.nih.gov |
| Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia | NIH | National Institute of Mental Health | 2025 | $1,125,194 | August 15, 2025 | August 14, 2027 | HONG, L ELLIOT ELLIOT | reporter.nih.gov |
| Opioid actions on the habenulo-peduncular circuit | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,124,858 | September 15, 2024 | July 31, 2029 | HNASKO, THOMAS | reporter.nih.gov |
| Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality | NIH | National Institute on Aging | 2023 to 2025 | $1,124,327 | February 15, 2023 | January 31, 2027 | MEHTA, NEIL | reporter.nih.gov |
| Randomized Controlled Trial of Dyadic Financial Incentive Treatment for Dual Smoker Couples: Evaluation of Efficacy, Mechanisms, and Cost Effectiveness | NIH | National Cancer Institute | 2024 to 2025 | $1,120,707 | September 8, 2023 | August 31, 2028 | VANDELLEN, MICHELLE RENEE | reporter.nih.gov |
| Varenicline and mobile behavioral assistance for tobacco cessation in HIV care in India. | NIH | National Cancer Institute | 2021 to 2022 | $1,119,891 | September 23, 2021 | May 1, 2023 | KRUSE, GINA RAE | reporter.nih.gov |
| Molecular Mechanisms Regulated by FOXM1 in Chronic Lung Remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,119,330 | June 1, 2020 | March 3, 2023 | KALINICHENKO, VLADIMIR | reporter.nih.gov |
| Cortical and subcortical neurophysiology in terminating movement | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,116,751 | December 1, 2023 | November 30, 2028 | SWANN, NICOLE CHRISTIANE | reporter.nih.gov |
| Cannabis Relapse: Influence of Tobacco Cessation | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,109,799 | September 30, 2010 | June 30, 2025 | HANEY, MARGARET | reporter.nih.gov |
| Genetic basis of nicotine withdrawal in a reduced complexity cross | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,108,380 | July 1, 2018 | April 30, 2025 | DAMAJ, M. IMAD | reporter.nih.gov |
| Vaping in Childhood and Adolescence: Cognitive and Behavioral Consequences | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,106,000 | September 15, 2022 | July 31, 2027 | DORAN, NEAL | reporter.nih.gov |
| Artificial Intelligence for effective communication to promote vaping cessation on social media | NIH | National Cancer Institute | 2024 to 2025 | $1,101,512 | September 1, 2024 | August 31, 2029 | LI, DONGMEI | reporter.nih.gov |
| NATIONAL ADDICTION AND HEALTH DATA ARCHIVE PROGRAM. PERIOD OF PERFORMANCE APRIL 1, 2024 - MARCH 31, 2026. | NIH | National Institute on Drug Abuse | 2025 | $1,086,994 | April 1, 2024 | March 31, 2026 | PIENTA, AMY | reporter.nih.gov |
| Incentive salience and the neuropsychological underpinnings of cue-induced smoking relapse | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,085,138 | July 15, 2012 | April 30, 2026 | VERSACE, FRANCESCO | reporter.nih.gov |
| Building Stochastic Actor-Oriented Models to investigate social network influences on youth nicotine product use transitions and to simulate different intervention effects across contexts | NIH | National Cancer Institute | 2024 to 2025 | $1,081,260 | September 12, 2024 | August 31, 2029 | THRASHER, JAMES | reporter.nih.gov |
| Elucidating Mechanisms of Pregnancy's Protective Effect on Drug Abuse Using Integrated Data Analysis | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,080,723 | March 1, 2021 | November 30, 2024 | MASSEY, SUENA HUANG | reporter.nih.gov |
| Understanding and mitigating exacerbated nicotine use resulting from Pavlovianinteroceptive conditioning | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,079,328 | July 1, 2023 | April 30, 2028 | BEVINS, RICK A | reporter.nih.gov |
| E-Cigarette Use among U.S. Adolescents and Young Adults: Longitudinal Associations with Tobacco Use and Health and Dimensions of Risk and Protection | NIH | National Cancer Institute | 2023 to 2025 | $1,064,420 | December 15, 2022 | November 30, 2026 | EVANS-POLCE, REBECCA J | reporter.nih.gov |
| Cellular and molecular mechanisms of cigarette smoking-induced Paneth cell abnormality | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,063,125 | July 1, 2020 | April 30, 2025 | LIU, TA-CHIANG | reporter.nih.gov |
| Effects of Tobacco & ENDS Policies on Patterns of Adolescent ENDS Use | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,059,608 | July 1, 2021 | April 30, 2025 | KELLY, BRIAN C | reporter.nih.gov |
| Evaluating the Effect of E-cigarette Policies on Youth Tobacco Use | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,059,043 | June 1, 2018 | September 1, 2023 | PESKO, MICHAEL | reporter.nih.gov |
| Methadone-Maintained Smokers Switching to E-Cigarettes | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,058,359 | September 30, 2021 | June 30, 2025 | ABRANTES, ANA M | reporter.nih.gov |
| Enhancing Relapse Prevention with rTMS: Dose-Response Parameters for Smoking Cessation | NIH | National Cancer Institute | 2021 to 2022 | $1,047,080 | June 1, 2018 | May 31, 2025 | SHEFFER, CHRISTINE ELIZABETH | reporter.nih.gov |
| Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells | NIH | National Cancer Institute | 2021 to 2023 | $1,042,735 | September 17, 2019 | August 31, 2025 | KASSIE, FEKADU | reporter.nih.gov |
| Molecular clock dysfunction in lung cellular senescence by environmental tobacco smoke | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,039,500 | May 1, 2019 | January 31, 2026 | RAHMAN, IRFAN | reporter.nih.gov |
| Cannabis Legalization's Effects on Youth and Adult Nicotine and Tobacco Use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,037,639 | September 15, 2023 | July 31, 2028 | FRIEDMAN, ABIGAIL S. | reporter.nih.gov |
| VCSIP2: CCC - Lead Application | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,037,156 | July 15, 2012 | May 31, 2024 | MCEVOY, CYNTHIA T | reporter.nih.gov |
| Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers | NIH | National Cancer Institute | 2022 to 2024 | $1,035,518 | July 11, 2022 | June 30, 2026 | SIEREN, JESSICA C | reporter.nih.gov |
| Compounded Neuronal Damage in Comorbid Cigarette Smoking and Addiction | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $1,031,212 | September 20, 2018 | April 30, 2025 | YODER, KARMEN K | reporter.nih.gov |
| Smoking and Cancer-Related Health Disparities among Sexual and Gender Minority Adults | NIH | National Cancer Institute | 2024 to 2025 | $1,031,095 | December 15, 2023 | May 31, 2026 | VELIZ, PHILIP T | reporter.nih.gov |
| Crosstalk between dopamine and glucocorticoids in high levels of nicotine intake and anhedonia in rats | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,029,375 | March 15, 2019 | December 31, 2025 | BRUIJNZEEL, ADRIAAN WILLEM | reporter.nih.gov |
| Nicotine, Airway Smooth Muscle and Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,019,998 | June 5, 2019 | October 31, 2023 | PABELICK, CHRISTINA MARIA | reporter.nih.gov |
| Vanderbilt Oregon COllaborative Scholar Training in Addiction Research (COSTAR) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,005,365 | August 15, 2024 | May 31, 2029 | TINDLE, HILARY A. | reporter.nih.gov |
| PROMINENT - IRB | NIH | National Cancer Institute | 2022 to 2024 | $1,002,551 | June 22, 2022 | May 31, 2025 | LOPEZ-BIGAS, NURIA | reporter.nih.gov |
| Prenatal Tobacco and Cannabis Exposure: A Translational Study | NIH | National Institute on Drug Abuse | 2021 to 2023 | $999,338 | September 30, 2018 | August 31, 2025 | THANOS, PANAYOTIS K | reporter.nih.gov |
| Cultural and Environmental Influences on Precursors to and Early Stages of Alcohol, Nicotine, and Cannabis Use in Black and Latinx Youth | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $995,678 | December 8, 2021 | November 30, 2026 | SARTOR, CAROLYN E | reporter.nih.gov |
| Development and Expansion of Digital Tools to Support Smoking Cessation | NIH | National Cancer Institute | 2021 | $995,470 | September 15, 2019 | September 14, 2022 | STEINBERGER, SARA | reporter.nih.gov |
| Latinos Kick Buts: Mobile Engagement and Cessation Support for Latino Smokers Phase II | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $991,893 | August 1, 2015 | June 30, 2023 | CUPERTINO, ANA PAULA | reporter.nih.gov |
| The potential of kava in enabling tobacco cessation - its holistic effects in managing stress and insomnia associated with abstinence | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $984,579 | August 1, 2023 | January 31, 2027 | XING, CHENGGUO | reporter.nih.gov |
| Impact of preconception and onward exposure to air pollution on growth trajectories of infants and children (R01) | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $978,645 | September 3, 2019 | May 31, 2025 | ZHANG, JUNFENG | reporter.nih.gov |
| Impact of a reduced nicotine standard on young adult appeal for menthol and non-menthol cigarettes | NIH | National Institute on Drug Abuse | 2021 to 2022 | $977,754 | May 1, 2020 | April 30, 2024 | COHN, AMY M | reporter.nih.gov |
| Distress Tolerance and Smoking Cessation | NIH | National Institute on Drug Abuse | 2021 to 2023 | $976,034 | November 6, 2021 | May 31, 2026 | ADDICOTT, MERIDETH A. | reporter.nih.gov |
| Tobacco Treatment Training for Cancer Care Providers | NIH | National Cancer Institute | 2021 to 2025 | $975,031 | August 1, 2017 | June 30, 2028 | OSTROFF, JAMIE S. | reporter.nih.gov |
| Partnering with Pregnant and Postpartum Women to Co-Create a Novel Intervention to Reduce Tobacco and Cannabis Use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $963,792 | September 15, 2024 | August 31, 2027 | DE GENNA, NATACHA | reporter.nih.gov |
| A Mentoring Program in Patient-Oriented Tobacco Dependence and Implementation Science Research | NIH | National Institute on Drug Abuse | 2021 to 2025 | $963,227 | March 1, 2018 | March 31, 2028 | SCHNOLL, ROBERT ADAM | reporter.nih.gov |
| Impact of State Policies on Smoking among Individuals with Substance Use Disorder | NIH | National Cancer Institute | 2021 to 2022 | $950,690 | April 22, 2019 | March 31, 2024 | COOK, BENJAMIN LE | reporter.nih.gov |
| Interpreting the regulatory mechanisms underlying the predisposition to substance use disorders | NIH | National Institute on Drug Abuse | 2021 to 2022 | $948,600 | August 15, 2018 | June 30, 2023 | PFENNING, ANDREAS ROBERT | reporter.nih.gov |
| State-of-the-Art Synthesis of Interventions to Promote Quit Intentions and Smoking Cessation | NIH | National Cancer Institute | 2021 to 2023 | $947,604 | July 1, 2021 | June 30, 2025 | SHEERAN, PASCHAL | reporter.nih.gov |
| Integrative 'Omics of Transcriptome Complexity in COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $944,308 | April 1, 2021 | November 30, 2026 | SAFERALI, AABIDA | reporter.nih.gov |
| Mechanisms of defective mitophagy and cellular senescence in HIV associated COPD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $938,582 | July 15, 2019 | June 30, 2025 | UNWALLA, HOSHANG JEHANGIR | reporter.nih.gov |
| Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse: An RCT of CBT for Insomnia in Adults who Smoke | NIH | National Institute on Drug Abuse | 2024 to 2025 | $936,989 | August 1, 2024 | June 30, 2029 | LI, CHIANG-SHAN RAY | reporter.nih.gov |
| Biomarker of Lung Disease in African Americans | NIH | National Heart, Lung, and Blood Institute | 2021 | $934,082 | August 15, 2018 | May 31, 2023 | BOWLER, RUSSELL PAUL | reporter.nih.gov |
| A CRISP(e)R approach to alleviating HIV-associated COPD | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $932,356 | September 1, 2024 | May 31, 2028 | CHINNAPAIYAN, SRINIVASAN | reporter.nih.gov |
| Nicotinic Modulation of the Cognitive Control System in Late-Life Depression | NIH | National Institute of Mental Health | 2021 | $927,396 | July 29, 2020 | November 30, 2022 | TAYLOR, WARREN D | reporter.nih.gov |
| Multi-component Intervention for Diabetes in Adults with Serious Mental Illness (MIDAS) | NIH | National Institute of Mental Health | 2021 | $924,387 | September 1, 2018 | July 31, 2024 | SOMMERFELD, DAVID H | reporter.nih.gov |
| Decoding tobacco-related oral cancer ecosystem by integrative approach | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2023 | $919,904 | September 1, 2022 | August 31, 2025 | TAN, AIK CHOON | reporter.nih.gov |
| Young Adults Responses to E-Cigarette Advertisement Features and the Effects of Restricting Features on Tobacco Use | NIH | National Institute on Drug Abuse | 2021 to 2023 | $913,641 | August 16, 2019 | March 31, 2024 | STEVENS, ELISE MARIE | reporter.nih.gov |
| Feasibility of cue-based treatment intervention to promote cessation among people who smoke lightly (<=10 cigarettes per day) or non-daily | NIH | National Cancer Institute | 2025 | $906,306 | September 11, 2025 | August 31, 2028 | FISH, LAURA | reporter.nih.gov |
| Sex Differences and The Influence of Ovarian Hormones on the Mechanisms that Promote Nicotine Withdrawal | NIH | National Institute on Drug Abuse | 2024 to 2025 | $904,411 | March 1, 2024 | December 31, 2025 | ODELL, LAURA ELENA | reporter.nih.gov |
| Transcranial Magnetic Stimulation and Tobacco Use Disorder: A Network-Level Approach with Attention to Sex as a Biological Variable | NIH | National Institute on Drug Abuse | 2021 to 2023 | $901,634 | August 15, 2018 | January 31, 2024 | PETERSEN, NICOLE | reporter.nih.gov |
| Multi-component INTERLUNG intervention to protect lung health in Nepal | NIH | National Institute of Environmental Health Sciences | 2025 | $893,525 | March 19, 2025 | February 28, 2030 | CHECKLEY, WILLIAM | reporter.nih.gov |
| Building a Cancer Epidemiology Cohort to Investigate Factors Associated with Higher Risk of Colorectal Cancer among Alaska Native People | NIH | National Cancer Institute | 2024 to 2025 | $893,216 | August 1, 2024 | July 31, 2029 | REDWOOD, DIANA | reporter.nih.gov |
| Actify! An mHealth mood management tool to improve population-level smoking cessation | NIH | National Institute on Drug Abuse | 2025 | $893,044 | September 1, 2025 | July 31, 2030 | HEFFNER, JAIMEE | reporter.nih.gov |
| Dynamic Signaling of NRG3-ErbB4 in the Hippocampus Mediates Nicotine Withdrawal Phenotypes | NIH | National Institute on Drug Abuse | 2021 to 2022 | $889,859 | April 1, 2018 | January 31, 2024 | TURNER, JILL R. | reporter.nih.gov |
| Cross-species studies of smoking effects on cognition and neuroinflammation in HIV | NIH | National Institute on Drug Abuse | 2021 | $884,326 | August 1, 2017 | July 31, 2023 | YOUNG, JARED WILLIAM | reporter.nih.gov |
| Macrophage LRRK2 activity regulates gut epithelial homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $882,538 | September 1, 2024 | June 30, 2027 | LIU, TA-CHIANG | reporter.nih.gov |
| Flavored e-cigarette use in adolescents: Behavioral, cellular, and epigenetic mechanisms | NIH | National Institute on Drug Abuse | 2021 to 2022 | $878,224 | April 1, 2018 | December 31, 2023 | DE BIASI, MARIELLA | reporter.nih.gov |
| Clarifying the role of tobacco retail outlets on maternal smoking during pregnancy and child secondhand smoke exposure | NIH | National Cancer Institute | 2021 to 2022 | $874,914 | May 2, 2019 | April 30, 2024 | FUEMMELER, BERNARD F | reporter.nih.gov |
| The Effects of Alternative Tobacco Product Marketing on Instagram, Facebook, and TikTok on Tobacco Use among Youth and Young Adults | NIH | National Institute on Drug Abuse | 2025 | $863,837 | July 1, 2025 | March 31, 2030 | KOSTYGINA, GANNA | reporter.nih.gov |
| Retail Environment for Tobacco and Marijuana in California: Impact on College Student Use | NIH | National Cancer Institute | 2021 to 2023 | $862,944 | February 1, 2018 | January 31, 2026 | HENRIKSEN, LISA ANNE | reporter.nih.gov |
| Endogenous Opioid Dysfunction, Stress, and Risk for Smoking Relapse | NIH | National Institute on Drug Abuse | 2021 to 2023 | $862,885 | September 30, 2003 | July 31, 2025 | AL'ABSI, MUSTAFA | reporter.nih.gov |
| Does Switching to Nicotine-containing Electronic Cigarettes Reduce Health Risk Markers? | NIH | National Institute on Drug Abuse | 2021 | $853,299 | August 15, 2018 | July 31, 2024 | FOULDS, JONATHAN | reporter.nih.gov |
| Genotoxicity and Repair of Tobacco-Specific Nitrosamine DNA Adducts | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $852,175 | July 20, 2012 | May 31, 2023 | SPRATT, THOMAS E | reporter.nih.gov |
| Exploiting zebrafish genetics to identify genes affecting addiction-related phenotypes. | NIH | National Institute on Drug Abuse | 2021 to 2022 | $847,264 | August 1, 2018 | May 31, 2026 | BRENNAN, CAROLINE HELEN | reporter.nih.gov |
| Health Opportunities & Promoters of Equitable Screening for Lung Cancer (Hopes for Lung Cancer) | NIH | National Cancer Institute | 2023 to 2025 | $842,331 | February 3, 2023 | January 31, 2028 | FLORES, EFREN | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Pennsylvania | Philadelphia, PA | 23 | $79.3 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 30 | $54.6 million | 0 | $0 |
| Yale University | New Haven, CT | 30 | $50.6 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 16 | $43.1 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 31 | $41.4 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 25 | $39.2 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 22 | $35.6 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 8 | $34.4 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 26 | $33.9 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 4 | $24.6 million | 0 | $0 |
| University of Louisville | Louisville, KY | 10 | $23.8 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 23 | $22.7 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 12 | $22.6 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 21 | $21.5 million | 0 | $0 |
| Brown University | Providence, RI | 11 | $21.3 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 22 | $20.7 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 9 | $19.7 million | 0 | $0 |
| Icf, Inc., LLC | Fairfax, VA | 3 | $18.8 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 15 | $18.3 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 20 | $17.7 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 19 | $17.3 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 11 | $17 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 2 | $16.8 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 23 | $16.5 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 13 | $16.4 million | 0 | $0 |
| Stanford University | Stanford, CA | 11 | $16.1 million | 0 | $0 |
| Washington University | Saint Louis, MO | 12 | $15.6 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 8 | $15.6 million | 0 | $0 |
| Duke University | Durham, NC | 19 | $15.5 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 13 | $15.2 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 15 | $14.3 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 10 | $13.7 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 12 | $13.5 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 11 | $13.4 million | 0 | $0 |
| Antidote Therapeutics, Inc. | Sykesville, MD | 1 | $13.1 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 9 | $13 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 10 | $12.3 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 6 | $12.2 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 7 | $12.2 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 9 | $11.9 million | 0 | $0 |
| Georgia State University | Atlanta, GA | 12 | $11.9 million | 0 | $0 |
| H. Lee Moffitt Cancer CTR & Res Inst | Tampa, FL | 8 | $11.7 million | 0 | $0 |
| Ohio State University | Columbus, OH | 14 | $11.5 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 7 | $11.4 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 11 | $11.3 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 12 | $11.2 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 7 | $10.9 million | 0 | $0 |
| Florida International University | Miami, FL | 10 | $10 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 11 | $9.8 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 4 | $9.7 million | 0 | $0 |
| Westat, Inc. | Bethesda, MD | 1 | $9.6 million | 0 | $0 |
| University of Florida | Gainesville, FL | 11 | $9.3 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 5 | $8.9 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 6 | $8.8 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 9 | $8.6 million | 0 | $0 |
| National Jewish Health | Denver, CO | 8 | $8.4 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 10 | $8.4 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 6 | $8.1 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 13 | $8 million | 0 | $0 |
| George Washington University | Washington, DC | 7 | $8 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 5 | $7.8 million | 0 | $0 |
| University of Rochester | Rochester, NY | 8 | $7.8 million | 0 | $0 |
| University of Houston | Houston, TX | 7 | $7.8 million | 0 | $0 |
| Roswell Park Cancer Institute Corp | Buffalo, NY | 5 | $7.7 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 12 | $7.6 million | 0 | $0 |
| Hennepin Healthcare Research Institute | Minneapolis, MN | 6 | $7.2 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 3 | $6.9 million | 0 | $0 |
| University of Hawaii | Honolulu, HI | 3 | $6.9 million | 0 | $0 |
| Emory University | Atlanta, GA | 7 | $6.6 million | 0 | $0 |
| Rand Corporation | Santa Monica, CA | 4 | $6.4 million | 0 | $0 |
| National Opinion Research Center | Chicago, IL | 3 | $6.2 million | 0 | $0 |
| University of Washington | Seattle, WA | 3 | $6 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 9 | $5.9 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 4 | $5.9 million | 0 | $0 |
| Astraea Therapeutics, LLC | Mountain View, CA | 1 | $5.6 million | 0 | $0 |
| New York University | New York, NY | 4 | $5.6 million | 0 | $0 |
| University of Tennessee Health Sci CTR | Memphis, TN | 4 | $5.3 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 6 | $5 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 4 | $5 million | 0 | $0 |
| Pennsylvania State Univ University Park | University Park, PA | 7 | $4.8 million | 0 | $0 |
| Provincial Health Services Authority | Vancouver | 1 | $4.7 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 2 | $4.6 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 6 | $4.4 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 6 | $4.4 million | 0 | $0 |
| University of Oregon Eugene | Eugene, OR | 4 | $4.4 million | 0 | $0 |
| Loma Linda University | Loma Linda, CA | 4 | $4.3 million | 0 | $0 |
| Washington State University | Pullman, WA | 2 | $4.1 million | 0 | $0 |
| Lehigh University | Bethlehem, PA | 2 | $4 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 3 | $4 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 4 | $3.9 million | 0 | $0 |
| University of Chicago | Chicago, IL | 7 | $3.8 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 4 | $3.8 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 4 | $3.7 million | 0 | $0 |
| Rutgers University Newark | Newark, NJ | 3 | $3.3 million | 0 | $0 |
| Baystate Medical Center, Inc. | Springfield, MA | 2 | $3.2 million | 0 | $0 |
| Northwestern University | Chicago, IL | 1 | $3 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 3 | $3 million | 0 | $0 |
| Eastern Virginia Medical School | Norfolk, VA | 2 | $2.9 million | 0 | $0 |
| SUNY Downstate Medical Center | Brooklyn, NY | 1 | $2.9 million | 0 | $0 |
| Wayne State University | Detroit, MI | 2 | $2.9 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 484 | $299,187,775 | 0 | $0 |
| 2024 | 516 | $288,336,726 | 0 | $0 |
| 2023 | 535 | $294,106,323 | 0 | $0 |
| 2022 | 541 | $295,917,799 | 0 | $0 |
| 2021 | 585 | $300,984,361 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.